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Eradication of residual tumor cells that are directly adjacent to vital tissue is a daunting 
challenge to surgeons. Because the field needs advances in intraoperative settings and a means for 
high-precision delivery of singlet oxygen for photodynamic therapy (PDT) of cancers, this 
dissertation outlines the development and application of a “pointsource” fiber optic device. The 
device offers highly localized and simultaneous delivery of sensitizer drug, light, and oxygen 
(components necessary for PDT) for cancer cell eradication in-vitro and in-vivo. The following 
chapters describe (a) the photokilling activity and precision of pointsource PDT in monolayer 
ovarian and brain cancer cells in-vitro by creating a halo of singlet oxygen, (b) minimal biomaterial 
fouling on the pace of sensitizer drug photorelease into in-vivo tumors of the head and neck cancer, 
and (c) synthesis of PEGylated pheophorbide sensitizers to enhance their bio-availability and 
uptake in cancer cells. (d) With the view of delivering nitrosamine drugs alongside singlet oxygen 
for dual chemo-photodynamic therapy, the photooxidation mechanism in N-nitrosamines was 
studied. 18O-isotopic labelling, photochemistry, tandem mass spectrometry and DFT calculations 
were utilized and an 18O label scrambling into aromatic but not aliphatic N-nitrosamine drugs from 
v 
 
molecular 18O2, was discovered. The oxygen atom exchange mechanism was proposed to occur by 
nitrosoperoxy intermediates and might provide a clue to new factors significant in nitrosamine 
phototoxicity. (e) Lastly, a review of the literature is presented on using singlet oxygen (1O2) to 
synthesize natural products and drugs that intends to draw a logical link between flow and batch 
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Chapter 1. Introduction 
 
1.1 Photooxidation Chemistry and Photodynamic Therapy (PDT) 
Radiation, chemotherapy and surgery have been the mainstays of treatment for cancer, 1-3 
but the eradication of residual tumor cells near vital organs remains a major challenge to 
surgeons.4-6 Photodynamic therapy (PDT), where singlet oxygen (1O2) is a key cytotoxic agent, is 
a successful treatment regimen. But treatment of tumors by conventional PDT is a two-step process 
that involves the systemic delivery of the photosensitizer followed by local illumination with a 
sensitizer-exciting wavelength of light.7-9 We have used basic concepts in organic and 
photochemistry to develop a one-step process for local delivery of sensitizer drug, oxygen and 
illumination in an effort to simplify the application of PDT.  Adjuvant chemo-photodynamic 
therapy has also been known to enhance the overall effect of treatment of tumors.10-12 For example 
chemotherapeutic nitrosamine drugs13-15 such as carmustine and lomustine are given in 
combination with PDT to improve the efficiency in treating several types of brain cancer.16-18  
The field is in need of a device that could potentially (i) offer precise delivery of sufficient 
sensitizer (with minimal loss), light and oxygen to generate adequate concentrations of cytotoxic 
singlet oxygen at the target site, (ii) limit near-neighbor effects in tumors that are close to vital 
tissue, and (iii) eliminate tumor hypoxia ensuring high local oxygen concentrations, sufficient to 
sustain PDT.   
In this thesis we have taken basic (Chapter 5) and applied (Chapters 2-4)  research 
approach, using organic synthesis and photochemistry as well as in-vitro and some preliminary in-
vivo studies, that are mutually dependent. In view of the utility in PDT,19-21 a “pointsource” fiber 
optic device capable of delivering the components necessary for PDT in a highly localized and 
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controllable fashion, was developed in our lab.22-26 This device offers high precision simultaneous 
delivery of sensitizer drug, light, and oxygen to produce singlet oxygen for photodynamic action 
in-vitro and in-vivo.  
Figure 1A shows the “pointsource” PDT device where red diode laser light and O2 gas 
travel through a hollow fiber optic and emerge from a silica probe tip attached at the distal end of 
the fiber. The surface of the silica probe tip is fluorinated to make it more Teflon like (hydrophobic) 
and loaded with sensitizer drug via photolabile alkene linker. Singlet oxygen produced by the 
attached sensitizer helps to cleave the linker27-29 via dioxetane intermediate (1) and photorelease 
the sensitizer drug (3) in the surrounding medium. The photoreleased sensitizer traverses a 
relatively long 0.25 mm distance in media and sensitizes the production of 1O2 away from the 
probe via light and O2 gas delivered from probe tip.  
Fluorination of the surface helps to reduced physical quenching of singlet oxygen,25 solves 
the problem of sensitizer re-adsorption onto the surface and improves localized concentration of 
oxygen around the probe which helps to maintain the efficiency of the probe even under hypoxic 
conditions. Thus far, four different kinds of silica probe tips have been synthesized, fluorinated-
sensitizer coated tip 4, only sensitizer coated tip 5,  only fluorinated tip 6 and uncoated bare tip 7 
(Figure 1B). The “pointsource” device with the variety of probe tips were utilized in the eradication 
of glioma U87 and OVCAR-5 cancer cells in-vitro30,31 and SQ20B tumors of head and neck in 
mice in-vivo32 and in understanding the mechanism of phototoxicity in nitrosamine drugs, which 








Figure 1B. Schematic presentation of various 
functionalized device tips 4-7 (inset on the 
right) pyropheophorbide sensitizer structure. 
The 5 × 8 mm2 cylindrical shape probe tips are 
made of porous Vycor glass. 
Figure 1A. Schematic presentation of the “pointsource” fiberoptic PDT device with fluorinated 
probe tip 4 and mechanism of sensitizer release after scission of dioxetane intermediate that arose 
from a [2 + 2] addition of singlet oxygen to the ethene bond. A cutaway view of the hollow fiber 
core, delivery of visible light and O2 through the fiber to the tip causing the photorelease of the sensitizer molecules, is shown.  
 
 
1.2 Sections in the Thesis 
The chapters to follow describe in detail, (a) Eradication of glioma cells in-vitro - the 
precision of pointsource PDT in the eradication of glioma (U-87) and ovarian cancer (OV5) cells 
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in-vitro by creating a halo of singlet oxygen. The efficiency of delivering sensitizer drug and 
singlet oxygen was assisted by an autocatalytic mechanism as can been seen in Chapter 2.  
(b) Biomaterial fouling in-vivo - the resistance to biomaterial fouling on the surface of the 
fluorinated PDT device tips probe tips its effect on the pace of sensitizer photorelease in-vivo. 
Biomaterial (e.g., proteins, cells, etc.) from SQ20B head and neck tumors and whole blood was 
used for an assessment of fouling of the silica tips by adsorption. Amount of biomaterial on the 
probe surface was quantified by bicinchoninic acid assay (BCA) and X-ray photoelectron 
spectroscopy (XPS) measurements and data summarized in Chapter 3.  
(c) New triPEG-galloyl pheophorbide sensitizer - the efficient synthesis of a specialized 
silica tip for an optical fiber device capable of delivering oxygen, light and a cleavable 
tripolyethylene glycol (PEG)-galloyl pheophorbide sensitizer, all components necessary for 
photodynamic therapy. The hydrolytic stability of the attached PEGs and the extent to which the 
PEG groups enhance solubility will also be discussed in Chapter 4. The new triPEG-galloyl 
sensitizer has the potential for use in intraoperative pointsource photodynamic therapy which aims 
for precision treatment of residual disease.  
(d) Photooxidation in nitrosamines - the photooxidation mechanism in N-nitrosamines was 
studied as described in chapter 5. Integrative approaches such as 18O-isotopic labelling 
chemistry,33-35 photochemistry, tandem mass spectrometry (HPLC-MS, HPLC-MS/MS) and 
density functional theory (DFT) calculations, were exploited to reveal the products of an oxygen 
exchange route in nitrosamine photochemistry. This may provide a clue to new factors significant 
in nitrosamine phototoxicity.  
(e) A review - of the literature on using photogenerated singlet oxygen (1O2) in the synthesis 
of natural products and drugs. The visible-light sensitized production of 1O2 is not only useful for 
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synthesis, it is extremely common in nature. Chapter 6 intends to draw a logical link between flow 
and batch reactions—a combination that leads to the current state of 1O2 in synthesis.  
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Chapter 2. “Pointsource” Delivery of a Photosensitizer Drug and Singlet Oxygen: 
Eradication of Glioma Cells In-vitro 
 
2.1 Introduction 
Conventional photodynamic therapy (PDT) techniques1 to treat tumors, systemically 
administer the sensitizer relying on homing to the appropriate site. There are examples of 
sensitizers conjugated to compounds or nanoparticles that lead to improved photodynamic therapy 
(PDT) results,2-7 sensitizer conjugation to, for example, metal particles or silica have been seen to 
increase PDT efficiency8,9 and singlet oxygen production.10-14 As we mentioned in chapter 1,  have 
developed a “pointsource” device that simultaneously delivers all the components essential for 
PDT in highly localized regions.   
In this chapter, we describe the application of our pointsource micro-optic device (Figure 
1) in killing glioblastoma cells in monolayer in-vitro. Briefly, pheophorbide molecules readily 
cleave off of the silica probe tip by oxidation of the ethene linker (Figure 1b and c)15 and emits 1O2 
which is used to kill glioblastoma cells.  Such oxidation processes resulting in bond cleavage16 
based on singlet oxygen chemistry17-20 have been of interest to us.  
Our interests are also in adsorption reactions that participate on silica surfaces. In recent 
work, we developed surface coatings (designed as a repellent fluorosilane probe surface) for 
enhanced pheophorbide photorelease of up to 99% of the ethane bonds broken in toluene.21 This 
fluorinated silica surface was also used for sensitizer drug release and photokilling of ovarian 





Figure 1. Pointsource device for targeted singlet oxygen delivery: (a) Red laser light and oxygen 
gas traveled through the hollow fiber optic and emerged from the probe tip. We used 200 mW 
output from a 669 nm laser and an O2 gas flow rate of ~0.2 ppm/min through the probe tip. The probe tip was held vertically in a perpendicular orientation above the cells so as not to kill them 
by mechanical action. (b) The fiber is equipped with a 5 × 10 mm2 (d × l) pheophorbide modified 
silica tip with a photocleavable ethene linker. The probe design includes a covalently bound 
nonafluorosilane to improve sensitizer photorelease into the surrounding medium. (c) A view of 
the singlet oxygen-generating probe tip is shown with sensitizer photorelease and factors that relate 
to the glioma cell killing mechanism. The sensitizer traverses a relatively long 0.25 mm distance, 
which stands in contrast to the short ~150 nm diffusion distance of 1O2 in H2O. The sensitized production of 1O2 also occurs away from the probe tip through diffusion of the pheophorbide via light and O2 delivered from the probe tip.   
Based on recent work21-22, we sought to answer chemical and biological questions in the 
drug photorelease process. For example, can we explain mechanisms of sensitizer uptake into the 
cells and the precision of killing when the probe tip is placed in U87 monolayers? Our reasons for 
pursuing this work are (i) to address significant challenges in the clinic in removing cancers to 
minimize damage to normal tissue,23-24 and (ii) to identify potential benefits of the pointsource 
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approach over conventional systemic photosensitizer delivery, particularly for PDT in the brain, 
where sensitizer delivery is problematic due to the blood brain barrier. Here, we describe detailed 
studies of the pointsource PDT technique, using principles of organic chemistry and photobiology 
for a basic understanding of interfacial phenomena for sensitizer-photorelease control and cell-
killing precision. In one respect, our work bears similarity to an optical fiber system developed by 
Kandler et al.25 which is ideal for cultured neurons and brain slices containing caged reagents for 
photo-uncaging reactions where the light spot is focused. 
 
2.2 Results and Discussion 
2.2.1 Cell Phototoxicity and Sensitizer Uptake 
Initially, we carried out control experiments to find conditions for efficient cell killing. 
Figure 2 (light red bars) shows the percent U87 cell viability, but with a device probe tip that was 
devoid of any sensitizer molecules. Here, pyropheophorbide-a spiked into U87 cell samples 
followed by light and oxygen from the device tip was used as a control. The U87 cell viabilities 
were analyzed 24 h post-treatment with a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay. These controls demonstrate that greater than 90% cell killing is achievable 
with 0.5 µM pheophorbide after 1 h. The cell viability decreases as we add higher 
pyropheophorbide-a concentrations due to greater concentrations of 1O2. Our control experiments 
also demonstrate that the pyropheophorbide-a toxicity in the dark is minimal (i.e. 0-3% for 0.025-
1.0 µM pheophorbide and 4% for 2.5 µM pheophorbide). Evidence for a photosensitized oxidation 
process is that in the absence of sensitizer, light, or O2 the cell viability was ~97%. In the absence 
of sensitizer, but the presence of light and O2 for 1 h the cell viability was 92-94%. 
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 Figure 2. Comparison of sensitizer uptake efficiency in the dark after 1 h (light red bars) with 
phototoxicity effects on U87 cells treated by a bare-tipped device devoid of sensitizer, but sparging 
O2 with red light irradiation with externally added pheophorbide (dark blue bars). Cells were digested for the uptake measurements. Cell viability was assessed by MTT assay and results are 
shown as percent relative to control cells. Each value represents an average of two or more 
experiments.  
 
Figure 2 (dark blue bars) shows the concentration of pheophorbide that was taken up by 
U87 cells in MEM media. The dose of pheophorbide added to the cells ranged from 0.025 to 2.5 
µM, which corresponded to cellular uptake ranging from 0.01 µM to 0.138 µM. Despite the 
difference in the amounts of pheophorbide introduced, over 1 h the quantity of pheophorbide taken 
up was relatively fixed 15-24%, where the uptake appeared to be a linear relationship over this 
concentration range (slope = 0.152; R2 = 0.9977). 
The data from Figure 2 taken together point to a 92% cytotoxic response for the delivery 
of 0.5 µM and uptake of 0.08 µM uptake of pheophorbide after 1 h. Although the porous silica 
probe tip readily loads different amounts of pheophorbide, the information in Figure 2 helped us 




2.2.2 Course of the Sensitizer Drug Photorelease in Phosphate Buffered Saline (PBS)  
We have used a probe tip with 7-nmol pheophorbide covalently-bound to the working front 
face. Figure 3 shows the percent of sensitizer photoreleased from the probe tip into 0.20 mL PBS. 
The plot shows a sigmoidal photorelease behavior. From 0 to 30 min, the photorelease was slow 
and was then followed by rapid photorelease. After 1.5 h, there was a deceleration. After 2 h, we 
found that ~10% of the sensitizer had departed from the probe tip, although most of the ethene 
bonds were consumed (92-95%). The amount of sensitizer adsorbed on the tip was 82±3% based 
on solvent washes with DMSO and n-butanol. This can be understood in terms of limited solubility 
of the sensitizer in PBS, thereby increasing its tendency to adsorb to the fluorinated silica probe 
surface. 
 Figure 3. A time-sequence analysis of pheophorbide photoreleased free from the probe tip of the 
device in PBS at 25 °C (solid circles) and fluence from the tip (solid triangles). The concentration 
of pheophorbide was measured by fluorescence spectroscopy at the indicated times. The values 
shown here are an average of 3 or more measurements.  
 
We previously showed that externally irradiated silica-conjugated sensitizer samples also 
produce a sigmoidal photorelease in n-butanol.26 There was a kinetic likeness in the photorelease 
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although the sigmoid was 7.7-fold steeper in the n-butanol than the PBS. Silica surface 
properties29-34 and factors including greater solubility in n-butanol than PBS play key roles in the 
extent of the pheophorbide retention on the silica tip surface. The results were similar from internal 
irradiation (described here) vs external irradiation26 of the sensitizer solid, where increasing light 
intensity in the former was a correlation with, but not causation of the sigmoidal behavior.  
As might have been expected, the light intensity emerging through the tip increased over 
the course of the PBS experiment. Power meter measurements have correlated the amount of light 
delivered through the tip with the fraction of detached sensitizer. Figure 3 shows that after 2 h, 
there is a net 10% sensitizer photorelease, which only yielded a 23% increase in the light intensity 
through the probe tip. With the increased light delivery, the affect may be one of increasing the 
1O2 concentration available at the end of the fiber adjacent to the probe tip. But, we did not attribute 
the increasing light intensity as playing a significant role in causing the sigmoidal photorelease 
behavior.   
Guided by the results of the micro-tipped device for sensitizer photorelease in PBS, we 
proceeded to investigate the efficiency of the pointsource device for killing glioma cells in-vitro. 
 
2.2.3 Fiber Tip-Guided Sensitizer Delivery for Cell Killing in Discrete Locations  
We have used the device to demonstrate sensitizer photorelease and global phototoxicity 
to U87 cells in MEM-media. The device contained pheophorbide-attached probe tips, and cell 
viability was measured 24 h after device treatment by live/dead assay and fluorescence 
microscopy. Here, the phototoxicity was evaluated in 14 mm diameter microwell experiments.  
Figure 4 shows a sigmoidal behavior for the photokilling, analogous to the photorelease 
behavior in solution (Figure 3). From 0 to 30 min, the cell killing was slow which was followed 
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by an acceleration and then deceleration at 1.5 h. The increasing sensitizer release and light 
intensity emerging through the tip over the course of the experiment was roughly proportional to 
the photokilling (inversely proportional to the normalized viability by live/dead assay). The 
phototoxicity reached a maximum of 79% after 2 hours (Figure 4). We did not observe 100% 
killing under our experimental conditions. 
 
Figure 4. Time-sequence analysis of phototoxicity effects on U87 cells in 14 mm diameter 
microwell experiments treated with the device tip (solid circles) and fluence from the tip (solid 
squares). Cell viability was assessed by live/dead assay and results are shown as percent relative 
to control cells. Each value represents an average of two experiments.  
 
 
2.2.4 “Lengthening” the Toxic Radius of Singlet Oxygen 
Although the diffusion distance of 1O2 is short35,36 with toxicity that does not extend much 
beyond ~100 nm37-39 sensitizer release from our device gives a diffusible photocatalyst that 
effectively increases it. This was shown in our examination of the cell killing radius, where we 
placed the device tip 0.25 mm above U87 cells spread into a monolayer on a 200-µL microwell 
plate (diameter = 14 mm). In-vitro toxicity experiments and imaging were done under the 
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supervision of Dr. Imran Rizvi. Figure 5 shows the photokilling radius as a function of time. The 
non-viable, propidium iodide-stained detached cells were aspirated as part of the standard protocol 
for the live/dead assay. Consequently the images in Figure 5 show viable green attached cells. The 
radius of cell killing increases and proceeds from 0.1 to 2.9 mm for treatment times of 0.5 to 2.0 
h, respectively. Compare the insets for “control” and treatment time = 0 h (Figure 5), which shows 
that cell viability with only light and O2 for 1 h is ~95% indicating that the sensitized formation of 
1O2 is required for the cell photokilling. A limited number of peripheral cell deaths were observed 
based on the fluorescence intensity of the attached cells from the no treatment image to those lying 
outside of the treatment zones.   
 
Figure 5. Device tip treatment of a U87 cell monolayer (154 mm2 area) revealed a radius of 
photokilling as a function of time. Regions of the confocal fluorescence images show the probe tip 
radius in a white dashed line, the radius of photokilling, and that of the plate edge. The cells were 
stained with calcein AM (green/live) for 30 min. Magnification 10×. (In-vitro imaging were done 







Our data support the mechanism depicted in Scheme 1. Visible light and oxygen gas 
emerge from the pointsource tip. The ethene group reacts with 1O2 for sensitizer release, following 
dioxetane cleavage, availing the sensitizer’s phototoxic activity to the U87 cells.  
Notice there was an increased photokilling rate from 0.5 to 1.0 h (270 cells/min) relative 
to earlier 0 to 0.5 h (173 cells/min) or later in the reaction 1.0 to 2.0 h (182 cells/min). Thus, it 
follows the radius of cell killing increases in the mid-point of the reaction. The notion was the 
probe tip is most lethal at 0.5 to 1.0 h when the photorelease rate was at its fastest. We know as 
the result of work with native silica that using fluorinated silica increases the photorelease.26 In 
addition to a Teflon-like repellent surface, evidence is for reduced physical quenching of 1O2 with 
the fluorinated silica compared to native silica21, which is an important factor in the self-
accelerated sensitizer release.  
We view 1O2 as a key species initiating events causing phototoxicity. Red-light irradiation 
of pheophorbides mainly proceeds by a Type-II (singlet oxygen) photosensitized mechanism40,41 
rather than a Type-I mechanism involving superoxide, hydroxyl radical and related species.42,43 It 
was evident from Figure 2 that of the sensitizer delivered, ~20% diffused into the cells, but we did 
not discriminate whether cell death depends more on extracellular or intracellular 1O2. Although 
an interconnection for the extracellular route could, in principle, be made with a membrane-
impermeable sensitizer.44 The diffusion coefficients of 1O2 or of pheophorbide were not estimated 




Scheme 1. Sensitizer drug and 1O2 delivery and glioblastoma cell killing mechanism 
 
2.3 Conclusion  
We describe a micro-optic device, which combines a diode laser, a hollow fiber optic, and 
a porous silica probe tip, to deliver a pheophorbide (sensitizer) and singlet oxygen. The sensitizer 
photocleaves away from the probe tip and diffuses through media until it reaches the glioma cells. 
A rapid photorelease function was identified about midway through the reaction. This builds on 
the previous work that was published in 201326, which found an autocatalytic-assisted photorelease 
of a sensitizer bound to a fluorosilane-coated silica surface into butanol and octanol solutions. 
17 
 
Development of the device for cancer eradication applications requires good precision in 
cell killing. Precision is important in treatment of cancers like glioma to minimize damage to 
critical normal nearby tissue.23,24 Additional experiments will grow from these initial experiments 
including optimization sensitizer release, sensitizer cell uptake, light dose rates, and also probe tip 
shape and surface conditioning to further enhance the cell killing. Our basic message is the 
pointsource approach has potential benefits compared to conventional systemic photosensitizer 
delivery for PDT. Its significance may include the treatment of brain tumors, e.g. glioblastoma 
multiforme. That the device tip delivers 3O2 is an essential (and somewhat indispensable) feature 
of the technique. The device can, in principle, connect to fiber optic methods to improve cell-
killing precision in oxygen-poor sites during PDT. 
 
2.4 Experimental Section 
2.4.1 Materials and Methods 
Sterile DMSO, chloroform, hydrofluoric acid, and propidium iodide solution (1 mg/mL in 
water, dead cell stain) were purchased from Sigma Aldrich (St. Louis, MO). Calcein AM (live cell 
stain), fetal bovine serum (FBS), and the MTT reagent were purchased from Life Technologies 
(Carlsbad, CA). Pyropheophorbide-a was purchased from Frontier Scientific (Logan, UT). 
Aqueous-based tissue solubilizer solution was purchased from PerkinElmer (Waltham, MA). 
Pierce® BCA protein assay kit was purc hased from Thermo Scientific (Rockford, IL). Minimum 
Essential Medium Eagle (Mod.) 1× (MEM), Dulbecco's Phosphate-buffered salt solution (PBS) 
and 5,000 I.U./mL penicillin/streptomycin and 50-mg/mL streptomycin were purchased from 
Mediatech (Herndon, VA). U87 MG ATCC® HTB-14™ cells were purchased from ATCC 
(Manassas, VA). To make complete MEM growth media, 1% (v/v) 5,000 I.U./mL 
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penicillin/streptomycin and 50-mg/mL streptomycin and 10% (v/v) FBS was added to a 500 mL 
bottle of MEM media. Cell culture glass bottom dishes (29 mm glass well size and 14 mm 
microwell) and #1 cover glass (0.13-0.16 mm) were purchased from In-Vitro Scientific 
(Sunnyvale, CA). Falcon 35 mm cell culture dishes and 24-well cell culture plates were purchased 
from Becton Dickinson Labware (Franklin Lakes, NJ). Corning’s code 7930 porous Vycor glass 
(PVG) was purchased from Advanced Glass and Ceramics (Holden, MA). 
 
2.4.2 Device Fabrication and Instruments 
 We have used this device previously.22 A 3-ft long fiber optic was purchased from 
Fiberoptic Systems, Inc. (Simi Valley, CA). It had an internal 1.1-mm diameter Teflon gas flow 
tube from the distal end to a T-valve that was surrounded by excitation fibers, as well as a 1.4-mm 
diameter black polyvinyl chloride jacket. The Vycor was shaped into cylindrical pieces 5 × 10 
mm2 (d × l) with a Buehler IsoMet Low Speed Saw (Model 11-1280-160), a Buehler ultrasonic 
disk cutter (Model 170), and a Buehler variable speed grinder-polisher. A hole 1.5 × 7.0 mm2 (d × 
l) was bored into the glass pieces with a dremel drill (Model 200) to fit to the fiber optic and was 
glued in place with ethyl cyanoacrylate. The synthesis of the pheophorbide-modified probe tips 
was carried out using a procedure as previously described.15,26 The amount of sensitizer covalently 
bonded to the probe tips was obtained to be 70 nmol. The diameter of the sensitizer molecule is 
~20 Å and pore sizes in the silica are ~40 Å. The penetration depth of the sensitizer is 0.08 mm 
along the outer faces of the probe tip. Light was delivered from a 669 nm CW diode laser (model 
7404, 700 mW, 4.1 A output, Intense Inc., North Brunswick, NJ) that was connected to the optical 
fiber and the power (1 W/cm2, spot size 0.196 cm2) was determined with a VEGA Laser Power 
Energy Meter (Ophir Laser Measurement Group, LLC, North Logan, UT). With the optical fiber 
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pinned to a translation stage (OptoSigma Corp., Santa Ana, CA) for ±0.1 mm precision movement, 
the diode laser was connected to its proximal end through an SMA connector. Based on a previous 
report27, the O2 gas flow rate through the probe tip was ~0.2 ppm/min as measured by a Clarke-
type oxygen electrode. The amount of sensitizer covalently attached was determined by monitoring 
its Soret absorption (λ = 415 nm) after liberation from unused probe tips on dissolution with 40% 
(v/v) aqueous hydrofluoric acid and extraction with chloroform. The total amount of sensitizer 
remaining on the probe tip after photorelease was measured in terms of mV using a Labsphere 
integrating sphere (North Sutton, NH) attached to a Fluke 79 Series II Digital Multimeter (John 
Fluke Mfg. Co., Vail, AZ). The multimeter was calibrated prior to use and the amount of covalently 
bound and adsorbed sensitizer were obtained from calibration curves. Fluorescence measurements 
were made with a SpectraMax M5 Multi-Mode Microplate Reader from Molecular Devices 
(Sunnyvale, CA). Absorbance measurements were made with an Evolution 300 UV-Vis 
Spectrophotometer (Thermo Fisher Scientific, Franklin, MA). 
 
2.4.3 Sensitizer Photorelease in Phosphate Buffered Saline (PBS) 
Oxygen gas and 669 nm excitation light, intensity of 1 W/cm2 (measured with fiber, 
without cap) were delivered for 2 h, through the fiber optic to probe tip loaded with covalently 
bound sensitizer dipped in a 200-µL PBS solution. From the photocleaved pheophorbide PBS 
solution 50 µL was sampled out at 0.5, 1, 1.5 and 2 h periods and diluted with 50 µL DMSO to 
measure fluorescence of the sensitizer. The photocleavage of sensitizer away from the probe tip 
was followed by fluorescence in solution (λex = 405 nm, λem = 675 nm) using the plate reader. The 
concentration of photosensitizer was obtained from the pre-constructed calibration curves of 
pheophorbide in (1:1) (v/v) DMSO:PBS solution. The amount of pheophorbide photoreleased was 
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calculated as follows: % photorelease  = [(photorelease/loading per area)] × 100. A 1/10th portion 
of the cap was dipped in 200-µL PBS solution and the quantity of dye that photocleaved was based 
on the amount of sensitizer covalently attached (7 nmol) to the front face of the cap (20 mm2 area). 
The amount of sensitizer adsorbed was measured by soaking the cap in 1 mL n-butanol solution 
for 24 h followed by fluorescence measurements using the plate reader. 
 
2.4.4 Cellular Uptake in U87 MG Cell Monolayer 
Human brain carcinoma cells (U87 MG) were maintained in complete MEM growth media 
at 37 °C in a 5% CO2 incubator. U87 cells (100,000 per well) were seeded in a 24-well cell culture 
treated plate and maintained at 37 °C in the 5% CO2 incubator. Twenty-four hours later, 0.20 mL 
volume of MEM media (without phenol red) containing concentrations of pyropheophorebide-a 
ranging from 0.025 to 2.5 μM in 1% (v/v) DMSO were added to the cells under subdued light 
conditions. The cells were incubated with the pyropheophorebide-a containing media for times 
ranging from 0.5 to 2 h. At each time point, the 0.20 mL of the supernatant media was removed 
from each well and diluted with 0.20 mL DMSO to determine the amount of pheophorbide 
remaining in the media by fluorescence using a microplate reader. The pheophorbide taken up and 
associated with the membrane of the U87 MG cells was extracted in 200-µL of the tissue 
solubilizer solution by digesting the cells for 30 min and the concentration of pheophorbide in the 
cell lysates was measured by fluorescence. Intracellular and bound concentrations of pheophorbide 
were quantified from pre-constructed calibration curves of known concentration range of 
pheophorbide in cell lysates. The total protein content of the cell lysates was determined using the 
BCA protein assay kit, and calibration curves prepared from known concentrations of BSA in the 




2.4.5 Phototoxicity of Pyropheoporbide-a in U87 MG Cell Monolayer  
U87 cells (210,000 per well) were plated in a 35-mm cell culture dish in complete MEM 
media and maintained at 37 °C in a 5% CO2 incubator for 24 h. A concentration range of 
pyropheophorbide-a in 1.0 mL MEM media (0.025-2.5 µM) was added to U87 cell monolayer. 
Immediately after addition of the media containing pheophorbide, the cells were treated with the 
device fitted with a “bare” tip at 669 nm laser, 150 mW/cm2 intensity and continuous oxygen 
sparging for 0.5 or 1.0 h. Control conditions such as ‘no treatment’, ‘light only’ and ‘dark control’ 
containing 2.5 µM pheophorbide were also done to ensure the reliability of the data. Post-device 
treatment, the media containing pheophorbide was aspirated and fresh complete growth MEM 
media was added to each treatment and control dish, and maintained at 37 °C in a 5% CO2 
incubator. Next day, cell viability was measured by assay28 and the surviving fraction was 
normalized to the ‘no treatment’ controls. 
 
2.4.6 Treatment Procedure 
U87 cells (170,000 per well) were plated in 29 mm glass bottom cell culture dish with 14 
mm glass bottom micro-well insert, in complete MEM media and maintained at 37 °C in a 5% 
CO2 incubator. Before treatment, media were aspirated and 0.20 mL complete growth MEM media 
with 1% (v/v) DMSO were added to the cell culture dish. The probe tip loaded with covalently-
bound sensitizer was placed 0.25 mm above the cells. Device treatment was carried out for 0.5 to 
2 h periods with 669-nm light with an intensity of 1 W/cm2 (measured with fiber, without cap) 
with continuous oxygen sparging, as ‘treatment’ groups. Controls such as ‘no treatment’ control, 
‘light only’ control with the bare tip and pheophorbide-loaded ‘tip only’ control were done to 
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evaluate the toxicity coming from only light or 1% (v/v) DMSO in MEM media. Post-device 
treatment, DMSO-containing MEM media were removed, complete growth MEM media were 
replenished in their place and cells were maintained at 37 °C in 5% CO2 incubator. To determine 
phototoxicity after 24 h, the media were removed from the cells, the cells were washed with PBS 
solution and then incubated for 30 min in a live/dead assay made of 0.001% (v/v) Calcein AM 
(live cell stain) and 0.002% (v/v) propidium iodide (dead cell stain) in PBS. The confocal 
fluorescence images of the stained cells were taken on the Olympus FV-1000 confocal using a 10× 
objective for the entire 14 mm glass microwell. The 488 nm line from an Argon ion laser with 
paired with a FITC filter set and a 559 nm diode source paired with a TRITC filter set were used 
to detect cleaved Calcein to label live cells. Cell viability was quantified from the fluorescence 
images using Image J software, where the surviving fraction was normalized to ‘no treatment’ 
controls. Importantly, the red fluorescence was lowered due the loss of detached cells during 
treatment and washing steps prior to imaging. However, this did not impact the analysis because 
cell viability was measured using Calcein AM (green fluorescence). 
 
2.4.7 Sources of Error 
Errors arise from the following sources: (i) volumes were recorded by drawing the media 
up into a 250-µL Hamilton syringe (±5 µL resolution; equates to 2.5% error). (ii) Media 
evaporation took place (e.g., tens of microliters could be lost over the course of the experiment). 
However, media were added every 30 min to account for this to maintain the volume at 200 µL. 
(iii) The concentration of the pheophorbide in the PBS was based on its fluorescence via its 
extinction coefficient (accuracy ±0.1 µM). (iv) The diameter of the light spot that emerged from 
the tip was measured with a ruler. It was 0.196 cm2 viewed by eye (accuracy ~20%). The 
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measurement of the fluence (mW/cm2) of light had an error of ~1%. (v) The normalized cell 
viability was calculated as the relative absorbance of the MTT reagent using the plate reader. The 
procedure of incubation with MTT reagent and extraction with DMSO, pipetting out 200-µL 
sample for absorbance introduces error of 2-5% in the cell viability calculation. (vi) The radius of 
photoxicity was measured using the same protocol described in the ‘Treatment Procedure’ section, 
using the Image J software “circle tool” option which introduced a ~1% error.  
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Chapter 3. Fluorinated PDT Device Tips and Their Resistance to Fouling for In-vivo 
Sensitizer Release 
 
3.1 Introduction  
As we discussed in Chapter 2, our pointsource PDT device produced a highly defined 
killing radius of glioma U871 and OVCAR-5 cancer cells in-vitro2. This observation raises key 
questions about limitations of pointsource PDT that have not yet been addressed. Does the device 
tip biofoul? Would biofouling be expected to arise during the time course of a typical PDT session? 
Do cells adhere to the tip and impede sensitizer photorelease? Does fluorination of the tip increase 
biofouling resistance in the pointsource PDT technique? 
Proteins, cells or microorganisms, in this manuscript called “biomaterial”, are known to 
adhere to surfaces, such as hydrophilic silica3,4, but less to hydrophobic fluorinated silica5. Indeed, 
polymers have been developed that have antibiofouling coatings, such as fluoropolymers and 
poly(ethylene glycol) (PEG) polymers.6-8 Some surfaces offer added biofouling protection by the 
production of reactive oxygen species (ROS). A vanadium pentoxide nanoparticle surface as a 
haloperoxidase mimic is known to produce singlet oxygen and resist biofouling.9 A porphyrin-
modified film that produced 1O2 was found to have antibacterial activity10 and anti-biofouling 
activity11. Similarly, silica/polydopamine/silver nanoparticle12, copper iodide nylon13 and 
electrochemical surfaces14, which produced ROS were found to resist biofouling. A self-cleaning 
superhydrophobic surface containing TiO2 nanoparticles was also found to photooxidize bovine 
serum albumin15. 
Thus, our hypothesis was that inhibition of sensitizer release in pointsource PDT device 
(Figure 1) will scale with biomaterial adsorption on the device tip. We had also tested the 
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hypothesis that sensitizer turnout levels will be better maintained based on the presence of a 
fluorosilane coating (tip 1) compared to the native silica surface (tip 5). We have analyzed whether 
surface biomaterial fouling limits tip output of sensitizer in pointsource PDT.  
 
 Figure 1. Schematic presentation of the pointsource PDT technique with various device tips. (a) 
Diode laser light and O2 gas are passed through a hollow fiber optic and emerge through the silica tip that is functionalized by a sensitizersilane and/or fluorosilane outer layer. An inset on the left 
shows the sensitizer structure. (b) The proposed mechanism is shown summarizing the steps in the 
sensitizer release system of tip 1. Much of the laser light is distributed out of the end of the tip. 
The device tip leaves behind the sensitizer upon conversion of the ethene to a dioxetane 3 and 
additional 1O2 is generated away from the tip. (c) Shown is a photograph of four device tips [sized 5 × 10 mm2 (d × l)] and chemical drawings of the bottom of tips with the anchored groups or 
silanol. 
 
In this chapter, we report on the biofouling of pointsource PDT device tips tested after 
placing the tip in contact with the surface of a surgically-exposed flank tumor (SQ20B tumors in 
nude mice). Figure 2 shows an image of the device tip placed on the exposed tumor surface. In 
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other experiments, device tips were soaked in whole blood as a phantom body fluid. Overlapping 
chromophores make the delivery of sensitizer into the tumor or blood samples difficult to 
quantitate. For this reason, fouling effects of the device tips were quantitated by a sensitizer 
photorelease inhibition analysis. Data were also collected with a bicinchoninic acid assay (BCA) 
and X-ray photoelectron spectroscopy (XPS) to quantitate the amount of biomaterial (e.g., 
proteins, cells, etc.) adsorbed on “dummy” tips 6 and 7, which contained no sensitizer. The results 
not only show that tip 1 biofouls by ~8%, based on experiments in the presence and absence of 
biomaterial, but retains a rapid sigmoidal release feature indicative of an autocatalytic mechanism. 
 Figure 2. A schematic of the cylindrical device tip held vertically, through an incision revealing 
the SQ20B tumor on the flank of a nude mouse. Red laser light and oxygen gas travel through the 
hollow fiber optic. Sensitizer, 3O2 and 1O2 emerge out the device tip. (All in-vivo procedures were performed by Joann M. Miller) 
 
3.2 Results 
Studies were performed on device tips that were biofouled through exposure to one of two 
types of media (mouse flank tumor and rat whole blood). The effects of biofouling on sensitizer 
photorelease were evaluated. After biofouling effects are established, repellent materials could be 




3.2.1 Effects of Biofouling on Device Tip Sensitizer Release 
Initially, we conducted experiments to quantitate biofouling of the device tip by contact 
with SQ20B tumors. Sensitizer photorelease inhibition—which can occur from the adhering of 
tumor biomaterial—was used as evidence for device tip biofouling. Development of head and neck 
cancer model in mice and all the in-vivo procedures were conducted by Joann M. Miller in Dr. 
Theresa M. Busch’s laboratory. 
Table 1 shows that exposing the tip to SQ20B tumor affects the yield of sensitizer 
photorelease. When exposed to tumor for 2 h in the dark, Table 1 (entries 1 and 5, and 2 and 6) 
show an 8% reduction in tip 1, and an 18% reduction in tip 5. The inhibition of sensitizer 4 
photoreleased was lower for fluorinated tip 1 compared to the native tip 5 (~10%). We found that 
the reduction in amount of sensitizer released was similar for tips biofouled with tumor and with 
blood (Table 1, compare entries 1 with 3, and 2 with 4). The tips were then dissolved by 
hydrofluoric acid and show that 5-8% of sensitizer remained bound to the surface, which indicates 




Table 1. Tumor- or blood-contact dependence of the photorelease of sensitizer 4 from device tips 
1 and 5 into n-butanol a 




sensitizer on tip 
% covalently-
bound sensitizer 
remaining on tip b 
1 1 tumor 77±2 17±5 6±2 2 5 40±2 53±5 7±3 
3 1 blood 79±2 16±5 5±2 4 5 38±3 55±5 7±4 
5 1 none 85±2 9±3 6±5 6 5 58±3 34±5 8±4 
a The device tip was placed in contact with the surface of a surgically-exposed flank tumor or 
presoaked in blood or n-butanol for 1 h under subdued light. The tip was then affixed to the hollow 
optical fiber, delivering O2 and 669 nm laser light through the tip (irradiance = 51 to 550 mW/cm2, time = 0 to 2 h) and the amount of 4 released determined after 1 h. After the 5 mm diameter 
operating front face of the device tip was exposed to tumor or blood, sensitizer photorelease was 
monitored in n-butanol. The amount of 4 adsorbed on the tip was determined by Soxhlet extraction 
with methanol at ~70 °C for 24 h. b The last remaining covalently-bound sensitizer was quantified 
by removal with HF and analysis of the Q-band (λ = 663 nm) of the sensitizer by UV-Vis 
spectroscopy judged against a prior constructed calibration curve of the sensitizer. Experiments 
were carried out 3 or more times. 
Figure 3 shows the time-course of sensitizer photorelease from device tips 1 and 5 after 
exposure to the tumor or whole blood. That is, the photorelease in n-butanol was carried out after 
the tip had been in contact with biological media. Fluorinated tip 1 gave a sigmoidal photorelease, 
whereas the native silica tip 5 gave a slower (pseudolinear) photorelease. Furthermore, the amount 
of sensitizer adsorbed to tip 1 was three times less compared to tip 5 as revealed by Soxhlet 
extraction with methanol at 68-70 °C for 24 h, to detach any adsorbed sensitizer. After the covalent 
ethene bridge bonding the sensitizer to the surface is broken, the amount of sensitizer 4 adsorbed 
to tip 1 was ~17% (35 nmol) and to tip 5 was ~54% (11 nmol). The tip fouling experiments 




Figure 3. The percent of sensitizer 4 photoreleased free from device tip 1 (black lines) and tip 2 
(grey lines) in 1 mL n-butanol. The tips were pre-exposed for 1 h to: (a) mouse flank tumor through 
an incision (●), (b) whole blood (▲), and (c) n-butanol (■). The concentration of sensitizer 4 was 
measured by UV−VIS following the sensitizer Q-band at λ = 663 nm.  
Similar to Figure 3, Figure 4 also shows the time-course of sensitizer photorelease from 
device tips 1 and 5. The difference between Figure 3 and 4 is that the latter was collected with the 
tip placed on the SQ20B tumor with light and oxygen purging through it for 1 h (amount of 
sensitizer delivered to tumor: 15% for tip 1 and 3% for tip 5). Once placed in n-butanol, Figure 4 
shows the fluorinated tip 1 release significantly more sensitizer (35%) than the native tip 5 (12%). 
That is, sigmoidal release was observed since the recording of sensitizer departure started at time 




Figure 4. A plot of remaining sensitizer 4 photoreleased into n-butanol vs time for tip 1 (■) and 
tip 5 (●). These points were collected after the tips already used for 4 photorelease in a mouse 
flank tumor for 1 h. 
 
3.2.2 Effect of Adsorption of Cellular Material  
The data show that biomaterial (e.g. proteins, cells, etc.) from the SQ20B tumors and rat 
blood adsorb onto the tip surfaces. The amount of this biofouling on both the fluorinated silica 6 
and native silica 7 surfaces was determined based on a BCA assay and XPS measurements. XPS 
analysis was performed by Dr. Bikash Mondal in Dr. Alan M. Lyons’s laboratoty.   
Table 2 and Figure 5 show the BCA assay results and the amount of biomaterial residue 
adhering to tips 6 and 7. A ~15% higher adsorption was observed on the native silica 7 compared 
to the fluorinated silica 6. In the first 5 min, there is a rapid adsorption (85 µg for 6; 102 µg for 7). 
After the biofouling increases sharply during the first 5 min, it slows to 2 h and continues for 10 




Figure 5. A plot of blood cells adsorbed to tip 6 (■) and tip 7 (●) vs time when immersed in blood. 
The quantity of protein was determined by a BCA assay after stripping with a SolvableTM solution.  
 
Table 2. Blood and tumor cell adsorption to fluorinated silica 6 and native silica 7 surfaces a 
time cell quantities adsorbed on device tips (µg) whole blood b SQ20B tumor b 
 fluorinated tip 6 native tip 7 fluorinated tip 6 native tip 7 
6 min 85±4 102±5 - - 
15 min 90±5 105±3 - - 
0.5 h 100±3 115±3 - - 
1 h 105±3 125±8 35±8 58±7 
3 h 127±3 140±5 - - 
10 h 198±8 201±5 - - 
a Device tips were pre-exposed to rat blood (100 µL) for 1 h. Error bounds were obtained from 2 
or more measurements. b Adsorbed tumor or blood cells were stripped off by SolvableTM and 




Figure 6 shows an XPS analysis of the adsorption of biomaterial from blood on tip 6. The 
ratio of the N 1s to Si 2p and C 2s to Si 2p peaks were used to determine the relative amount of 
protein and other biological materials on the surface.  During the first hour of immersion, the 
amount of biomaterial adsorbed on the surface increases rapidly with time.  The C 1s to N 1s ratio 
remains constant throughout this period, indicating that C and N adsorption rates are similar.  This 
rapid initial adsorption of biomaterials is consistent with the adsorption isotherm of protein studied 
on various surfaces22.  
 
Figure 6. Time profile for XPS peak area ratio changes of C 1s/Si 2p (▲), N 1s/Si 2p (●), and C 
1s/N 1s (■) of tip 6 immersed in whole blood.  
After 1 hour of immersion, however, the N 1s/Si 2p ratio remains relatively constant 
(Figure 6). This apparent stability may be due to the formation of a complete biomaterial coating 
on the silica tip after 1 h of immersion. This layer is sufficiently thick to completely cover the 
underlying silica, preventing detection of Si 2p peaks in the XPS spectrum, as shown in Figure 7. 
The N 1s (~400 eV) signal is characteristic of adsorbed biomaterial at the surface.23,24 Peak area 
ratio of N 1s/ Si 2p, C 1s/N 1s and C 1s/Si 2p were compared to eliminate any variation between 
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different XPS samples.25,26 Accumulation of biomaterial does continue, as shown in Figure 5 for 
the BCA assay results. However thicker layers of biomaterial would not be distinguished by XPS 
due to the limited penetration depth (5-30 nm) of the escaping electrons. Thus, once a sufficiently 
thick layer of biomaterial is deposited on the silica surface to obscure the Si 2p peak, XPS cannot 
be used to detect further biomaterial accumulation. 
 
Figure 7. XPS spectra of clean silica 6 and silica 6 contaminated by whole blood. (XPS analysis 
was performed by Dr. Bikash Mondal) 
 
3.3 Discussion 
 Some details are now available on how pointsource PDT device tips 1 and 5 are fouled. 
Tip fouling experiments were carried out where SQ20B tumors and whole blood showed sensitizer 
release inhibition of ~6% for 1 and ~10% for 5 after 1 h. Thus, the hydrophobicity of the 
fluorinated tip provides some protection against biofouling. Figure 3 shows sigmoidal release 
behavior of 4 for tip 1 that is attributed to an autocatalytic process, where surface fouling does not 
significantly inhibit the release of sensitizer.  
We now know that tip fouling was minimal because of the sensitizer turnout levels that 
were maintained. Thus, fouling is not expected to be problematic over the time course of a typical 
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PDT session; furthermore, the tips are intended to be replaced after each treatment. This is an 
important criterion to have met due to the sensitizer delivery feature of the pointsource PDT 
strategy.1 We demonstrate that ~15% less biomaterial adheres to the fluorinated silica than to 
native silica. The BCA assay shows a constant increase of biomaterial from 1 hour to 10 h while 
the XPS shows that the level after 1 h remains constant.  This is because once a complete and 
sufficiently thick layer of biomaterial forms on the silica surface, the underlying Si can no longer 
be seen by the XPS instrument. It makes sense that when silica is treated with nonafluorosilane 
the fraction of silicon observable on the surface by XPS at time = 0 (before protein adsorption) is 
smaller than native silica. The fluorinated silica surface does adhere proteins and cells—just less 
than the native silica surface due to the residual charges on the untreated silica. Bacteria could be 
present as a foulant, although there are more cells present than bacteria. Our work did not examine 
whether the adsorption of biomaterial is due to a hydrophobic and electrostatic interactions27-29, or 
other mechanisms.  
 Lastly, we now know there is a complimentary effect where the fluorinated tip 1 not only 
repels biofoulants better, it also suppresses surface 1O2 physical quenching30-32 for a more efficient 
sensitizer photorelease. It could be argued that added biofouling protection results from the 
production of 1O2 at the surface of tips 1 and 5 as has been observed for other surfaces which 
produce 1O2 or ROS.9-15 We believe that biomaterial on (or near) the tip where 1O2 is generated 
will retard and/or prevent fouling on that surface. The magnitude of this effect will depend on 
several factors. If sufficient 1O2 is generated in an environment with low amounts of proteins, cells, 
microorganisms, etc. then biofouling might, indeed, be prevented.  However, in an environment 
rich in proteins, cells, etc., then the 1O2 production rate would need to be sufficiently high to 
overcome the loading of biomaterial that could react with 1O2. Each cell, bacterium or protein 
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could consume many 1O2 molecules. Other studies33-35 have examined the reaction of 1O2 with 
biological media that produce peroxides, which can decompose and/or chemiluminesce36-50.   
 
3.4 Conclusion  
 There is still much research to be done before pointsource PDT can be used clinically. Data 
obtained from the tumor and blood fouling studies described here will contribute to the ongoing 
development of pointsource PDT.1 The pointsource PDT device tip was modified with 
nonafluorosilane to improve its protection against biofouling. The fluorinated tip led to improved 
biofouling resistance based on sensitizer photorelease performance.  
 Future studies could continue to resolve outstanding questions concerning a one-step PDT 
process (i.e. simultaneous delivery of sensitizer, oxygen and light) in order to simplify the 
application of PDT. Other device configurations could be benefitial. Advantages may exist for 
micropillar roughened device tips, such as 3D-printed superhydrophobic surfaces, which reduce 
the contact between the tip and tissue.41,42 Device tips could also be designed with different 
sensitizer types43-49 to customize delivery based on tumor type.50-52 Finally, research efforts could 
seek advantages for intraoperative use of pointsource PDT for precision treatment of residual 
disease. Research efforts are in progress in these directions. 
 
3.5 Experimental Section 
3.5.1 Materials and Methods 
(i) Device fabrication. A fiber-optic device with silica device tips 1 and 5 was used as 
described previously.1,30 Briefly, pieces of silica were fluorinated by soaking in 1×10-3 M 
3,3,4,4,5,5,6,6,6 nonafluorohexyltrimethoxysilane and then refluxed in toluene for 24 h. Any 
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nonafluorosilane that was not covalently attached to the silica surface was washed away by Soxhlet 
extraction in methanol for 24 h.  
 (ii) Tumor model. SQ20B head and neck squamous carcinoma cells (ATCC, Manassas, 
VA) were cultured in DMEM medium (ATCC) supplemented with 10% fetal bovine serum 
(Gibco, Carlsbad, CA), 2 mM L-glutamine (Gibco), 100 units/mL penicillin (Gibco), 100 μg/mL 
streptomycin (Gibco) and maintained in a humidified atmosphere with 5% CO2 at 37 °C. Cells in 
log phase were harvested, and resuspended at 2×107 cells/mL in a 1:1 solution of phenol red-free 
matrigel basement membrane matrix (BD Biosciences, San Jose, CA) and normal saline53-55. Each 
8-9–week old female athymic nude mouse (Charles River Laboratories in Frederick, MD) was 
inoculated with 1×106 SQ20B cells intradermally on the right and left flank of the mouse. The 
tumor suspension was in 50% matrigel. Animals were used for experiments two weeks after tumor 
inoculation when the intradermal tumors reached volumes of ~50-150 mm³. The mice were 
anesthetized by inhalation of isoflurane in medical air delivered through a nosecone (VetEquip 
anesthesia machine, Pleasanton, CA). An incision was made adjacent to the flank tumor and a skin 
flap was created in order to expose the tumor. A device tip (1 or 5-7) was placed on the tumor 
surface for 1 h. Once the device tip was in contact with the tumor, two drops of saline solution 
were applied to the exposed area to prevent dehydration of the tissue and its adhesion. After 
treatment, the device tips were removed and preserved in dry ice for further analysis.  
 
3.5.2 Sensitizer Photorelease Studies 
The bottom face of tips 1, 5-7 were placed (i) on the surgically-exposed surface of a SQ20B 
tumor grown intradermally on the flank of athymic nude mouse, or (ii) in 100 µL whole blood 
obtained from Sprague Dawley rats at 37 °C. The tips were placed for 1 h on the tumor or in blood 
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either (i) in the dark or (ii) with 669-nm laser irradiation via hollow fiber optic coupling with 
oxygen flowing through the tip. The tips were then rinsed with 5 mL saline and analyzed for 
subsequent sensitizer photorelease (attached to the device) from the tips into 1 mL n-butanol, 
quantified by monitoring the Q-band (λ = 663 nm) with UV−VIS spectroscopy (6). After 
photorelease in n-butanol, the device tips were subjected to Soxhlet extraction with methanol at 
68-70 °C for 24 h, thereby removing any adsorbed sensitizer, and then subjected to a previously 
described hydrofluoric acid stripping method (5) in order to determine the amount of sensitizer 
bound to the surface. Treatments were at a fluence rate of 51 mW/cm2 to 550 mW/cm2 over a 
period of 0 to 2 h.  
 
3.5.3 BCA Studies  
After exposing the front face of device tips to the SQ20B tumor or the Sprague Dawley rat 
blood, the tips were washed with 5 mL saline and the adsorbed biomaterial was stripped off with 
200 µL 20% (v/v) SolvableTM in 1 mL 1% SDS solution. The amount of biomaterial adsorbed on 
the device tips, as µg, was determined using BCA assay in comparison to the calibration curve of 
standard protein albumin.56,57 Experiments were carried out 2 or more times. From the plot, 10 µL 
blood has 876±20 µg protein. The compatibility of BCA assay in 20% (v/v) SolvableTM in 1 mL 






3.5.4 XPS Studies  
The flat front faces of tips were placed in 100 µL whole blood obtained from Sprague 
Dawley rats for various lengths of time at 37 °C. After exposing the device tips to the blood, the 
tips were washed with 5 mL saline and dried using a high vacuum freeze dryer lyophilizer. The 
amount of protein adsorbed on glass samples was analyzed with XPS using an Omicron 
Nanotechnology system equipped with an Al Kα X-ray source (1486.6 eV). A hemispherical 
analyzer (EA-125) was operated in constant analyzer energy (CAE) mode and equipped with one 
channel electron multiplier to measure the binding energies of the emitted photoelectrons. XPS 
spectra were collected under ultra-high vacuum (<1×10-8 torr) with high resolution scans (0.5 eV 
step size) over the range of binding energy (from 600 to 0 eV) to cover N 1s (~400 eV), O 1s 
(~532.8 eV) and C 1s-2p (~285-290 eV), for signals typical of adsorbed protein57. Surface areas 
with a diameter less than 1.5 mm were analyzed and referenced by setting C 1s peak to 284.8 eV 
to compensate for residual charging. Finally, the peak area ratios of N 1s/Si 2p, C 1s/N 1s and C 
1s/Si 2p were calculated to compare the amount of adsorbed protein on the silica surfaces58. 
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Chapter 4. Synthesis of an Poly(ethylene glycol) Galloyl Sensitizer Tip for a Pointsource 
Photodynamic Device 
 
4.1. Introduction  
Thus far, we have decribed a pointsource PDT device (Chapter 1) that channels O2 and red 
diode laser light through a silica probe tip and it can be implanted at the cancer cells in-vitro 
(Chapter 2) and at tumor site (Chapter 3). Briefly, the pointsource device generates singlet oxygen 
(1O2) which serves dual role, (a) causes the release of sensitizer through cleavage of a dioxetane 
intermediate (Scheme 1), and (b) leads to cell death. However, there is a need for further progress 
in device tip design and synthesis suited to releasing sensitizer molecules.  
Other research groups have reported on pheophorbide1-12 and chlorin derivatives13-22 for 
efficient photosensitized eradication of tumor cells by alleviating solubility and aggregation 
problems. We23,24 and others25-32 have observed that polyethylene glycol (PEG) groups bonded to 
chlorophyll sensitizers can increase their solubility in solution, cell uptake, and phototoxicity in 
cancer cells. But previous work23 with chlorin e6 had required chemically bonding each PEG group 
individually with the third PEG adding in low yield (triPEG-chlorin silica 2 and triPEG-chlorin 
Teflon/PVA nanocomposite 3, Figure 1). This led us to pose the question: Can three PEG groups 






Scheme 1. Self-sensitization, singlet oxygen formation and dye cleavage  
 
 
Thus, the aims of the present work were to (i) design a PEG sensitizer based on computed 
solubility via octanol/water calculations, (ii) fabricate triPEG-galloyl pheophorbide silica 1 as a 
new device tip material, and (iii) develop a synthetic approach with fewer steps to reach 1 and with 
increased stability of the PEG-sensitizer bond compared to the previously reported 2 and 323. As 
we will see, 1 is synthesized in fewer steps, and in higher overall yield and stability compared to 
2 and 3. Other aspects such as the efficacy for scaling up the production of the optical fiber device 






Figure 1. Chemical structures of the new triPEG-galloyl pheophorbide silica 1, and previously 
reported triPEG-chlorin silica 2 and triPEG-chlorin Teflon/PVA nanocomposite 3.23 
 
4.2. Results and Discussion  
4.2.1 Sensitizer Design and Solubility (Table 1) 
Short chain PEG groups, such as [–O(CH2CH2O)3CH3] when bonded to sensitizers can 
reduce self-aggregation33-38, and retain some propensity to localize in cell membranes compared 
to unsubstituted sensitizers24,39,40. Therefore, we surmised that a galloyl unit carrying three PEG 
groups could be bonded to pheophorbide silica end-tips of a pointsource PDT device. We were 
unsure whether the triPEG-galloyl pheophorbide would ameliorate the low water solubility 
problem to the same extent as the triPEG chlorin. Experimental log P measurements were desirable 
in octanol and water, but the sensitizer quantity is sparse in water. Thus, computed log P values 
were obtained with the ACD algorithm, which has performed well in predicting the log P values 
of drugs41-45.  
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Table 1 shows the computed log P values. TriPEG-galloyl pheophorbide and triPEG-
chlorin (entries 2 and 4) led to a lipophilic deamplification by 1.9 log units compared to 
unsubstituted sensitizers, respectively (entries 1 and 3). Lower log P values of PEGylated 
compounds would be expected, where their curling onto the porphyrin ring inhibits aggregation 
due to π-π stacking forces46-52. The reduced log P of the PEGylated pheophorbide versus native 
hydrophobic pheophorbide-a will make the former more accessible and less prone to aggregating, 
to potentially address the challenge sterilization of surgical margins. Next, the synthesis of triPEG-
galloyl pheophorbide silica 1 was carried out. 
 
Table 1.  Computed octanol-water partition coefficients (log P) with three [–O(CH2CH2O)3CH3] PEG groups appended to chlorin e6 and pyropheophorbide-a using the ACD program   
entry compound number of PEG groups computed log P 
1 chlorin e6 0 6.6 ± 1.6 a 
2 triPEG-chlorin e6 3 4.7 ± 1.7 a 
3 pyropheophorbide-a 0 7.2 ± 1.6 
4 triPEG-galloyl pheophorbide 11 3 5.1 ± 1.6 
a Reference 24. 
 
4.2.2 Synthesis (Schemes 2 and 3)  
Scheme 2 shows that triethyleneglycol monomethylether (PEG) 4 reacted with 4-
toluenesulfonyl chloride (TsCl) in presence of sodium hydroxide in THF to form PEG-tosylate 5. 
Similar to literature reports53-55, a potassium carbonate-mediated PEGylation of methyl gallate 6 
in acetone led to 7 which was followed by reduction with LiAlH4 in THF resulting in triPEG-
galloyl alcohol 8 in 58% yield after 3 steps. Scheme 3 shows that the pheophorbide methylester 9 
reacted with HBr in acetic acid to brominate the exocyclic alkene at the carbon 31 position and 
46 
 
subsequent nucleophilic substitution reaction with 8 in dichloromethane led to the triPEG-galloyl 
pheophorbide methylester 10 in 40% yield in 2 steps. The methyl ester 10 was hydrolysed by a 
reaction with potassium carbonate to form triPEG-galloyl pheophorbide acid 11. A condensation 
reaction of acid 11 with alkene 12 was carried out with EDC and DMAP to form triPEG-galloyl 
pheophorbide alkene ester 13 in 50% yield. Next, the fabrication of the photoactive surface 1 is 
described. 
Fluorinated silica 11 with loading ratio of 1:60 for Si–OH:C–F was prepared by reaction 
of silica with nonafluorotrimethoxysilane in toluene under reflux. The triPEG-galloyl 
pheophorbide alkene ester 13 was reacted with (3-iodopropyl)trimethoxysilane in NaH and THF  
and added to the pieces of fluorinated silica 11 [each piece was 0.33 g and sized ∼5 mm × ∼8 mm 
(d × l)] in refluxing toluene to reach 1 with loading of 115 nmol per g of silica (ratio of 
1860:111,400:1 for Si–OH:C–F:sensitizer). Unreacted nonafluorotrimethoxysilane and 13 were 
washed off of the silica by Soxhlet extraction in methanol. 
 






Scheme 3. Synthesis of triPEG-galloyl pheophorbide silica 1  
 
 
4.2.3 Structural Assignments (Figures 2 and 3)  
There are literature examples of synthetic modifications of the exocyclic alkene of 
pheophorbide to form an ether bond56,57. In our case, NMR spectroscopy58 was particularly useful 
in assigning structures. Figure 2 shows NMR data of 9 and 10 indicate the shift of the 31-proton 
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from 7.9 to 6.0 ppm, disappearance of the 32-alkene protons and appearance of 2 aromatic protons 
(Ar-H) at 6.55 ppm in the 1H NMR spectra for 10.  
COSY spectra for 10 showed correlation between the newly formed peak for 32-proton at 
2.19 ppm and 31-protons at 6.01 ppm. HSQC spectra for 10 showed that C peak at 107.6 belongs 
to Ar-H, 71.2 ppm belongs to Bz-H and 71.46 ppm belongs to 31-H. The regioselective attachment 
of triPEG-galloyl group at carbon 31 position of 10 was shown by HMBC spectra where correlation 
existed between (a) Ar-H (6.55 ppm) and Bz-C (71.2 ppm) of triPEG-galloyl group, (b) 31-H (6.01 
ppm) of porphyrin ring and Bz-C (71.2 ppm) of triPEG-galloyl group, and (c) Bz-H (4.6 ppm) and 
31-C (71.46 ppm) (Figure 11). Formation of 11 is evident by HRMS (+ESI) observed [M]+ = 
1128.5882 corresponded well with the calculated C61H84N4O16 [M]+ = 1128.5875.  
Figure 3 shows 1H NMR data of 13 indicating the appearance of 2 alkene protons at 6.08 
ppm and 8 aromatic protons between 6.90-7.32 ppm from the alkene linker. COSY spectra for 13 
showed correlation between peaks for the 17-proton at 4.32 ppm and 171-protons at 2.61 ppm and 
172-proton at 2.73 ppm. HSQC spectra of 13 showed that C peak at 29.96 belongs to Bz-H of 
alkene, 31.0 ppm belongs to 172-H, 29.8 ppm belongs to 171-H and 172.0 ppm belongs to 173 ester 
C=O. The attachment of alkene group by ester bond to the oxygen attached to carbon 173 position 
was confirmed by HMBC spectra of 13 where correlation was found between (a) Bz-H (4.97 ppm) 
of alkene linker and 173-C (172.0 ppm), (b) 172-H (2.73 ppm) and 173-C (172.0 ppm) and (c) 171-




 Figure 2. 1H NMR spectra for the pheophorbide methylester 9 and triPEG-galloyl pheophorbide 
methylester 10.  
 





4.2.4 Comparative Analysis (Table 2) 
Synthetic, stability and other device tip data are compared. We found that (i) the triPEG-
galloyl pheophorbide silica 1 was synthesized in higher yield compared to triPEG-chlorin silica 2 
and triPEG-chlorin Teflon/PVA nanocomposite 3. The number of steps to reach 1 was decreased 
and more efficient compared to 2 and 3 due to the ease of introduction of three PEGs through a 
galloyl unit. (ii) There was a greater hydrolytic stability of the PEG-sensitizer conjugate 1 (ether 
bond) compared to the labile PEG-sensitizer conjugates of 2 and 3 (ester bonds). Previously, 
researchers have examined PEG-drug conjugates through irreversible ether bonds and reversible 
ester bonds59-63. (iii) Figure 4 shows the silica tip with CF3CF2CF2CF2 groups where facile 
sensitizer release is expected. For example, PEGylated sensitizer molecules would otherwise 
adhere to non-fluorinated silica23. Thus, the fluorinated device tip yields repellent characteristics 
to discharge the sensitizer and also yields high oxygen concentrations consequently producing 
highly focused quantities of singlet oxygen. (iv) Lastly, synthetic efficiency is one parameter that 






Table 2. Comparative analysis of synthetic, stability and materials data 
 






% yield of alkene 
ester precursor 18% (over 4 steps) 3% (over 6 steps) 3% (over 6 steps) 
total number of 
synthetic steps 6  8  7  
sensitizer loading 
quantity (per g) 115 nmol 90 nmol 23 nmol 
stability of PEG  
(after 1 h) 
~0% decomposition 
at pH 2 and 8 b 
≥ 80% decomposition 
at pH 2 and 8 b 
≥ 80% decomposition 
at pH 2 and 8 b 
surface C–
F:sensitizer ratio 111,000:1 142,000:1 750,000:1 
O2 concentration in n-butanol in the 
presence of 0.2 g of    
1-3 at 25 °C 
0.522 mM 0.522 mM 0.559 mM 
Number of probe tips 
fabricated from 100 
mg sensitizer a 
4 2 5 
Total number of 
person hours required 
to fabricate a batch of 
12 probe tips (h) 
60 150 130 
 a Commercially available pyropheophorebide-a and chlorin e6. b The decomposition of the triPEG-galloyl pheophorbide 10 and triPEG-chlorin24 were measured 







 Figure 4. Scheme of pointsource PDT device: red laser light and oxygen gas emerge through the 
device tip and triggers the sensitizer release for singlet oxygen production away but in the near 





Because of the need to further advance the pointsource PDT technique64,65, a 
photocleavable triPEG-galloyl pheophorbide silica 1 was designed and synthesized. Unlike 2 and 
3 that required each of the three PEG groups to be introduced one at a time, 1 had the three PEG 
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groups introduced in one-step with a galloyl substituent. This is an advantage from the fabrication 
and scale-up perspective of a pointsource PDT device. 
With the completion of the synthesis of 1, next we will be able to examine whether a 
cylindrical, hemispherical, or rectilinear probehead is best for the fiber to get the right amount of 
sensitizer and oxygen delivered to kill cells directionally, e.g., in specific quadrants of a culture 
plate. Future work may also focus on 3D-geometric shaped TMOS/MeOH/H2O xerogels cast with 
flanges and ridges and with matrix porosities that can be increased66-69. To this end, pointsource 
PDT can augment the current tools available for intraoperative use with improved control for 
sterilization of residual cells. 
 
4.4 Experimental Section  
4.4.1 Computations  
Octanol/water partition coefficient calculations were conducted with the Advanced 
Chemistry Development Inc. (ACD) log P algorithm (version 10). 
 
4.4.2 Materials and Methods 
Methanol, dichloromethane, hydrofluoric acid (HF), tetrahydrofuran (THF), chloroform-
d, chloroform, N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), N,N-
dimethyl-4-aminopyridine (DMAP), tri(ethylene glycol) monomethyl ether (MW = 164.20), (3-
iodopropyl)trimethoxysilane, 3,3,4,4,5,5,6,6,6-nonafluorohexyltrimethoxysilane, methyl 3,4,5-
trihydroxybenzoate (methyl gallate),  and pyropheophorbide-a methylester were used as received 
from Sigma Aldrich. Synthesized products were purified by column chromatography using flash 
silica gel 200-400 mesh particle size. 1D and 2D NMR data were acquired on Bruker DPX400 
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MHz NMR instrument. HPLC data were obtained on a PerkinElmer 200 series instrument 
equipped with a bondclone 10 C18 column at 254 nm. UV-vis spectra were collected on a Hitachi 
U-2001 instrument. High-resolution mass spectrometry (HRMS) data were collected on an Agilent 
iFunnel 6550 Q-ToF LC/MS system.  
 
4.4.3 Synthesis of TriPEG-galloyl (8) 
Compound 8 was synthesized from diethyleneglycol monomethylether and methyl gallate 
in 3 steps following a modified procedure from literature2. Briefly, triethyleneglycol 
monomethylether (PEG) 4 was reacted with TsCl in presence of NaOH in THF to form PEG-
tosylate 5 which was further reacted with methyl gallate 6 in the presence of K2CO3 in acetone to 
form PEGyled methyl gallate of 7.  The ester group in 7 was reduced with LiAlH4 in THF to form 
triPEG-galloyl alcohol 8 in 58% yield. 1H NMR (400 MHz, CDCl3) δ (ppm): 6.62 (s, 2H), 4.57 (s, 
2H), 4.08-4.01 (m, 6H), 3.73 (ddd, J = 18.5, 5.8, 4.3 Hz, 6H), 3.64-3.57 (m, 6H), 3.56-3.50 (m, 
12H), 3.50-3.42 (m, 6H), 3.29 (s, 9H), 2.80 (t, J = 6.5, 5.8 Hz, 1H). 13C NMR (101 MHz, CDCl3) 
δ (ppm): 152.50, 137.38, 137.02, 106.20, 72.18, 71.85, 71.82, 70.67, 70.59, 70.45, 70.40, 69.71, 





4.4.4 Synthesis of TriPEG-galloyl-ether-31-pyropheophorbide Methyl Ester (10) 
Pyropheophorbide-a methylester (9) (50 mg, 0.091 mmol) and 30% HBr/AcOH (Aldrich, 
1.0 mL) were added to a 5 mL round-bottom flask and stirred at room temperature for 2 h. Acetic 
acid was removed under high vacuum (bath temperature was maintained at 30-40 °C) and the 
resulting concentrate was dissolved in anhydrous dichloromethane (10 mL). Galloyl-triPEG 8 (540 
mg, 0.91 mmol) and K2CO3 (102 mg, 0.76 mmol) were added, and the reaction mixture was stirred 
at room temperature for 12 h under N2 atmosphere. The reaction was quenched with water (5 mL), 
and extracted with dichloromethane (15 mL). The dichloromethane layer was washed with sat. 
NaCl solution (10 mL) and dried over anhydrous sodium sulfate. The solvent was removed under 
vacuum and the residue obtained was chromatographed on a silica column, eluted with 2% (v/v) 
methanol in dichloromethane to obtain 10 in 42% yield (43.0 mg, 0.038 mmol) and over 99% 
purity. HPLC: tR = 10.33 and 11.00 min (2 diastereomers of 10) 5% (v/v) water in acetonitrile 
solvent system. 1H NMR (400 MHz, CDCl3) δ (ppm): 9.71 (s, 1H), 9.53 (s, 1H), 8.57 (s, 1H), 6.52 
(s, 2H), 5.99 (q, J = 6.7 Hz, 1H), 5.36-5.03 (m, 2H), 4.65 (d, J = 11.7 Hz, 1H), 4.50 (dq, J = 11.8, 
6.0, 4.8 Hz, 2H), 4.32 (dt, J = 8.9, 2.6 Hz, 1H), 4.12 (t, J = 5.2 Hz, 2H), 4.01 – 3.26 (m, 55H), 3.17 
(d, J = 1.7 Hz, 3H), 2.81 – 2.49 (m, 2H), 2.29 (ddt, J = 14.6, 9.3, 4.8 Hz, 2H), 2.16 (dd, J = 6.6, 
2.2 Hz, 3H), 1.93-1.78 (m, 3H), 1.71 (t, J = 7.6 Hz, 3H), 1.29 (s, 1H), -1.73 (s, 1H). 13C NMR (101 
MHz, CDCl3) δ (ppm): 196.20, 173.48, 171.42, 160.37, 155.05, 152.63, 150.91, 148.98, 145.01, 
141.25, 141.22, 138.73, 137.85, 137.82, 136.32, 135.47, 135.39, 133.74, 132.79, 132.76, 130.54, 
128.47, 107.58, 107.55, 106.06, 104.12, 97.91, 92.77, 72.30, 71.95, 71.84, 71.45, 71.21, 71.17, 
70.69, 70.64, 70.55, 70.53, 70.50, 70.44, 69.58, 68.62, 59.03, 58.97, 51.71, 51.68, 50.02, 48.05, 
30.93, 30.91, 29.91, 29.89, 29.72, 24.57, 24.55, 23.21, 23.19, 19.50, 17.53, 12.11, 11.29, 11.20. 
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HRMS (+ESI): m/z calculated for C62H86N4O16 [M]+ 1142.6034, found: 1142.6039. UV−vis 
(CHCl3): λmax = 411 nm and 664 nm.  
 
4.4.5 Synthesis of TriPEG-galloyl-ether-31-pyropheophorbide Carboxylic Acid (11) 
TriPEG-galloyl pheophorbide 10 (43.0 mg, 0.038 mmol) was dissolved in tetrahydrofuran 
(2.0 mL) and methanol (4 mL). K2CO3 (10.2 mg, 0.076 mmol) dissolved in distilled water (1.6 
mL) was added and the reaction mixture was stirred at room temperature for 12 h. The reaction 
was monitored by TLC. After the completion of the reaction it was diluted with dichloromethane 
(20 mL) and washed with 2% acetic acid (10 mL), again with distilled water till the pH of the 
aqueous solution was neutral. The dichloromethane layer was separated and dried over anhydrous 
sodium sulfate. The solvent was removed under vacuum and the residue obtained was 
chromatographed on a silica column, eluted with 10% (v/v) methanol in dichloromethane to obtain 
11 in 95% yield (41.0 mg, 0.036 mmol) and over 99% purity. HPLC: tR = 7.49 and 8.35 min (2 
diastereomers of 11) 5% (v/v) water in acetonitrile solvent system. 1H NMR (400 MHz, CDCl3) δ 
(ppm): 9.69 (d, J = 22.2 Hz, 1H), 9.48 (s, 1H), 8.55 (d, J = 4.7 Hz, 1H), 6.48 (d, J = 5.0 Hz, 2H), 
6.09 – 5.85 (m, 1H), 5.37 – 5.00 (m, 2H), 4.64 (dd, J = 11.8, 5.1 Hz, 1H), 4.56 – 4.42 (m, 2H), 
4.38 – 4.26 (m, 1H), 4.07 (dt, J = 8.0, 5.2 Hz, 2H), 3.95 – 3.23 (m, 52H), 3.16 (d, J = 3.5 Hz, 3H), 
2.78 – 2.48 (m, 2H), 2.36 – 2.22 (m, 2H), 2.15 (t, J = 6.3 Hz, 3H), 1.81 (dd, J = 7.4, 3.1 Hz, 3H), 
1.69 (t, J = 7.6 Hz, 3H), 1.21 (s, 1H), -1.72 (s, 1H). 13C NMR (101 MHz, CDCl3) δ (ppm): 196.38, 
171.48, 160.35, 160.31, 155.13, 155.09, 152.58, 150.91, 149.00, 145.00, 141.29, 141.25, 138.82, 
138.75, 137.81, 136.32, 136.30, 135.56, 135.43, 133.70, 132.87, 132.73, 130.45, 128.44, 107.64, 
106.08, 104.10, 98.05, 97.73, 92.78, 72.26, 71.94, 71.81, 71.46, 71.39, 71.28, 70.67, 70.58, 70.50, 
70.47, 70.39, 70.37, 69.53, 68.58, 68.56, 59.01, 58.94, 51.56, 50.01, 48.00, 30.55, 29.72, 29.63, 
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24.61, 24.46, 23.20, 23.18, 19.48, 17.50, 12.08, 11.27, 11.24, 11.12. HRMS (+ESI): m/z calculated 
for C61H84N4O16 [M]+ 1128.5875, found: 1128.5882. UV−vis (CHCl3): λmax = 411 nm and 664 nm. 
 
4.4.6 Synthesis of TriPEG-galloyl-ether-31-pyropheophorbide-(Z)-alkene Ester (13) 
To 41.0 mg (0.036 mmol) of 11 in 10 mL anhydrous dichloromethane were added 30.7 mg 
(0.108 mmol) of alkene 12, 9.16 mg (0.072 mmol) of DMAP and 20.2 mg (0.108 mmol) of EDC 
under N2 atmosphere. The reaction was stirred overnight at room temperature. Upon completion 
of the reaction, solvent was removed under vacuum and the residue obtained was chromatographed 
on a silica column, eluted with 5% (v/v) methanol in dichloromethane to obtain 13 in 50% yield 
(25.0 mg, 0.018 mmol) and 93% purity. HPLC: tR = 8.72 and 9.59 min (2 diastereomers of 13) in 
5% (v/v) water in acetonitrile solvent system. 1H NMR (400 MHz, CDCl3) δ (ppm): 9.77 (s, 1H), 
9.58 (s, 1H), 8.59 (s, 1H), 7.32 – 7.23 (m, 2H), 7.15 (dd, J = 8.7, 2.5 Hz, 2H), 7.06 – 6.98 (m, 2H), 
6.98 – 6.90 (m, 2H), 6.52 (s, 2H), 6.08 (ddt, J = 16.6, 3.4, 0.8 Hz, 2H), 5.98 (q, J = 6.6 Hz, 1H), 
5.33 – 5.03 (m, 2H), 5.03 – 4.86 (m, 2H), 4.70 – 4.56 (m, 3H), 4.48 (dd, J = 11.7, 7.4 Hz, 2H), 
4.31 (d, J = 8.5 Hz, 1H), 4.18 – 4.06 (m, 2H), 4.01 – 3.25 (m, 52H), 3.18 (d, J = 2.0 Hz, 3H), 2.79 
– 2.49 (m, 2H), 2.42 – 2.22 (m, 2H), 2.15 (dd, J = 6.7, 1.9 Hz, 3H), 1.80 (dd, J = 7.3, 1.8 Hz, 3H), 
1.71 (t, J = 7.6 Hz, 3H), 1.26 (s, 1H embedded under grease peak 3H), -1.76 (s, 1H). 13C NMR 
(101 MHz, CDCl3) δ (ppm): 196.15, 172.84, 171.45, 160.38, 157.26, 156.80, 152.64, 149.00, 
144.98, 141.27, 138.76, 137.85, 136.28, 135.51, 133.73, 132.83, 130.58, 130.10, 130.05, 128.68, 
128.55, 128.50, 128.01, 116.24, 116.12, 107.58, 106.17, 104.11, 97.90, 92.86, 72.31, 71.96, 71.84, 
71.47, 71.21, 70.71, 70.66, 70.56, 70.53, 70.45, 69.60, 68.65, 65.93, 64.76, 59.05, 58.98, 51.62, 
50.00, 48.05, 31.07, 29.81, 29.72, 24.57, 23.19, 19.51, 17.51, 12.12, 11.29, 11.21. HRMS (+ESI): 
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m/z calculated for C77H98N4O19 [M]+ 1382.6841, found: 1382.6825. UV−vis (CHCl3): λmax = 411 
nm and 664 nm. 
 
4.4.7 TriPEG-galloyl Pheophorbide Modified Fluorinated Silica (1)  
Fluorinated silica 14 was prepared following previously established procedure70. Briefly, 
Vycor pieces were added to the nonafluorotrimethoxysilane in 0.07% (wt/wt) in toluene under 
reflux for 24 h under N2 atmosphere to obtain fluorinated silica 14 with loading ratio of 1:60 for 
Si–OH:C–F. Unreacted nonafluorotrimethoxysilane was removed by Soxhlet extraction in 
methanol for 24 h. The triPEG-galloyl pheophorbide alkene ester 13 was reacted with (3-
iodopropyl)trimethoxysilane in NaH and THF  and added to the pieces of fluorinated silica 14 
[each piece was 0.33 g and sized ∼5 mm × ∼8 mm (d × l)] in toluene under reflux for 24 h to reach 
1 with loading of 115 nmol/g of silica (ratio of 1860:111,400:1 for Si–OH:C–F:sensitizer). 
Unreacted adsorbed sensitizer was washed off of the silica surface by Soxhlet extraction in 
methanol for 24 h and washings with CH2Cl2 and THF. Amount of sensitizer loading was 
determined after dissolution of silica 1 in HF, extraction with chloroform, and monitoring the UV-
vis absorbance of the chloroform solution at λmax = 411 nm and 664 nm.  
 
4.4.8 Hydrolytic Stability  
The hydrolytic stabilities of triPEG-galloyl pheophorbide 10 and triPEG-chlorin24 were measured 
in 10% (v/v) water in methanol where the pH was adjusted to 2 or 8 with formic acid or ammonium 
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Chapter 5. Mechanism of Photochemical O-Atom Exchange in Nitrosamines with 
Molecular Oxygen 
 
5.1 Introduction  
Despite the decades-long interest in N-nitrosamine organic chemistry and toxicity,1,2 no 
photochemical O-atom exchange process with molecular oxygen has been reported. One paper,3 
speculated that an O-atom exchange between singlet oxygen (1O2) and N-nitrosamine would 
proceed by a 1,2,3,4-trioxazetidine intermediate (cycloNO3 species) (Scheme 1). In related 
papers,4-9 experimental and theoretical evidence have pointed to the intermediacy of a 1,2,3-
dioxazetidine (cycloCNO2 species) in the reaction of 1O2 with hydrazones, which cleaves the 
hydrazone C=N bond yielding carbonyls and N-nitrosamines.  
 




Little is known of the intermediates involved in the direct photolysis of nitrosamines in the 
presence of O2 and the formation of peroxy intermediates. Early studies of Tanikaga10 and Chow 
et al.11 were done in air-saturated solutions. Formed aminium radical cations (R2NH+∙), from 
protonation of aminyl radicals (R2N∙), were thought not react to react with O2 due to unaffected 
absorption signals at 10-3 M O2 concentrations.12 Past studies had focused on nitrosamine excited 
states, NO∙ release, and the formation of amine and imine, not on photooxygen atom exchange 
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chemistry. Indeed, nitrosamine photolysis studies mainly focused on N2-degassed solutions.11-16  
In this paragraph we review nitrosamine photochemistry to set the stage for our work. 
Using N2-degassed solutions, the direct photolysis of nitrosamines can lead to the homolysis of 
the N–N bond17,18 via excitation to the S1 and S2 states.19-21 For diarylnitrosamines, 
photodissociation of NO∙ occurs from the singlet excited state.15,22,23 The triplet state of 
diarylnitrosamine has a low propensity to dissociate NO∙.15 Later we will show that photoexpulsion 
of NO∙ from 1 and 2 is minor pointing to the importance of a triplet reaction in our system. For N-
dimethylnitrosamine, the first excited singlet state (11A’’) contains npO  π *NO character, while 
the second excited singlet state (21A’) contains npN  π *NO character.20 Chow et al.16 also found 
a direct excitation route [S0  T1 (n  π*) transition] for N-dimethylnitrosamine at 453 nm. The 
photolysis of alkyl nitrosamines leads to NO∙ release and aminyl radicals or aminium radical 
cations after protonation20,21 in the presence of acid.13 On the S1 excited surface, CASSCF 
calculations show that N-dimethylnitrosamine can lose NO∙ by loss of R2N–N=O planarity,20,24 
where subsequent reactions were stymied due to high-energy barriers so that recombination of NO∙ 
and R2N∙ is favored and regenerates ground-state nitrosamine. When originating from the S1 state, 
aminyl radicals can have lifetimes (τ) upward of 0.5 s.16 Consistent with a long lifetime, Geiger et 
al. found that UV photolysis of N-dimethylnitrosamine led to isotopic exchange for 15NO∙ from 
the S0  S1 transition but not the S0  S2 transition.25,26 Chow et al.16 also found that excitation 
N-dimethylnitrosamine to S2 led to NO∙ release and products such as imines (CH2=NHCH3 and 
CH2=NH) and methyl radical (CH3∙). Photolysis of N-nitrosopiperidine also yielded imines.11,16 
On the other hand, UV photolysis of 1 started with NO∙ release and led to Ph2NH, and after 
extended photolysis, carbazole as a secondary product. Photorelease of NO∙ has been recognized 
in other compounds, such as diazeniumdiolates.27-30 With time-dependent DFT calculations, an 
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O2-dependent process is known for n  π * excitation of CH3CH2NHN=O with isomerization and 
H-abstraction to reach CH3CH=NH.31  
Today, the potential for photochemical O-atom exchange in nitrosamines with O2 remains 
unexplored. We thought that an oxygen isotope labeling study would be useful since its use in 
rearrangement and cleavage reactions have helped deduce mechanisms in the past. For example, 
18O isotope labeling has helped deduce the mechanism of the Robinson-Gabriel oxazole 
synthesis32 and has proved useful in tracking peroxy-nitrogen and -sulfur species in reactions,33,34 
and other oxygen-transfer reactions.35-39 One example of 18O labeling described phenyl 
dioxaziridine (cycloNO2 species) arising in the photooxidation of phenyl azide40-47 and 
accompanying calculations.48,49  
Here, we describe a scrambling of O atoms in the photolysis of nitrosamines in the presence 
of 18O2. We report experiments and calculations that suggest a new oxygen atom exchange scheme. 
One feature is the presence of an intermediate, trioxazetidine (cycloNO3 species) as playing an 
important role in the reaction mechanism. HPLC/MS and HPLC-MS/MS were used to examine 
the photochemistry of four nitrosamines (N-nitrosodiphenylaniline 1, N-nitroso-N-methylaniline 
2, N-butyl-N-(4-hydroxybutyl)nitrosamine 3, and N-nitrosodiethylamine, 4). These nitrosamines, 
1-4, were chosen to vary in their number of phenyl and alkyl groups. The intention was to uncover 
a possible photoexchange process, and evaluate a substituent dependence for the process. DFT and 
TD-DFT calculations were also carried out. Experimental and theoretical evidence that supports 





Scheme 2. Photo 18O exchange process and generation of 18O-labeled nitrosamines  
 
 
5.2 Results and Discussion 
We thought that the research should focus on the photooxygen atom exchange mechanism 
of nitrosamines 1-4 because observations of the intermediates in O2-saturated solution have not 
yet been sought. Experiments and theoretical calculations have been conducted for determining 
the likely intermediates produced upon excitation of nitrosamine in the presence of 18O2. The 
proposed reaction scheme is shown in Scheme 3. The experimental photoexchange results will be 
discussed first, followed by product analyses and theoretical calculations. HPLC-MS/MS and 
HRMS analysis was performed by Dr. Marilene Silva Oliveira and Fernanda Manso Prado in Dr. 




Scheme 3. Proposed 18O exchange mechanism for generating the 18O-labeled nitrosamine  
 
 
5.2.1 Direct Excitation of Aromatic and Aliphatic Nitrosamines in the Presence of 
Isotopically Labeled Molecular Oxygen (18O2) 
Photolyses of 1-4 (5 mM) in 18O2-saturated CHCl3 solutions were carried out at room 
temperature by irradiation with a metal halide or tungsten light source. Table 1 shows that the 18O-
label was exchanged into nitrosamines 1 and 2, but not 3 and 4, as it will be discussed below. 
Figure 1 shows mass spectral data for 1 prior to and after photolysis for 3 h. The base peak at m/z 
= 199.08 is unlabeled 1 (M + H)+ and the peak with a +2 Da mass increase ([(M + 2) + H)]+, m/z 
= 201.08) is 18O-labeled 1. Peaks with m/z = 200 and 201 correspond to natural abundance of 
isotopomers containing 1.1% 13C and 0.21% 18O, respectively. The small peak at m/z = 202 is due 
to the isotopomer with the 18O label and the natural abundance of 13C (1.1%). Figure 9 shows mass 
spectral data for 2 prior to and after photolysis where a peak with a +2 Da mass increase is found 
for 18O-labeled 2. Table 1 shows that the 18O-label is photoexchanged with limited efficiency, 





























































Table 1. HPLC/MS Data of the Nitrosamine Percent 18O Exchange and Decomposition in the 
Presence of 18O2 in CHCl3  
nitrosamine irradiation time (h) 
relative abundance of isotopes (%) a percent 
decomposition 
(%) b [M+H]+ [(M+1)+H] + [(M+2)+H] + 
 (m/z = 199) 
0 100±0 17±2 1±0 0 
3 65±4 11±2 8±2 35±4 
 (m/z = 137) 
0 100±0 8±1 0±0 0 
3 50±2 4±0 12±3 50±2 
 (m/z = 175) 
0 100±0 12±1 1±0 0 
1 30±3 4±1 0±0 70±3 
 (m/z = 103) 
0 100±2 6±0 1±1 0 
0.5 48±2 3±0 0±0 52±2 
a Relative to the sum of area of the [M+H]+, [(M+1)+H]+, and [(M+2)+H]+ peaks.  




 Figure 1. HPLC-MS/MS analysis of (A) 1 prior to photolysis, and of (B) 1 with the 18O-label 
photochemically introduced. (HPLC-MS/MS analysis was done by Marilene Silva Oliveira) 
 
5.2.2 Nitrosamine Photolytic Instability 
HPLC-MS/MS was used to determine the percent yields of products in the photolysis of 1-
4 (Figures 6, 11, 14 and 17). It is clear that nitrosamine photodecomposition rates are increased as 
the number of alkyl groups are increased. The di- and monophenyl nitrosamines 1 and 2 only 
photodecomposed by 35±4% and 50±2% photodegradation after 3 h, respectively. In contrast, the 
amount of 3 and 4 remaining was far less. After 1 h photolysis, the amount of starting material 
remaining of 1 was 89%, of 2 was 77%, of 3 was 30%, and of 4 was 4%. Figure 2 shows the rate 
of appearance of 18O-labeled 2 is 1.4-fold greater than 18O-labeled 1, but that the rate of the 
photodegradation of 2 is greater by 1.5 fold than 1. Clearly, the dialkyl substituted nitrosamines 
decompose rapidly. The time to fully photodegrade 3 was 3 h and 4 was 2 h. The photolysis of 
nitrosamines 1 and 2 for 3 h led to the detection of amines, namely N,N-diphenylamine [m/z = 170 
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(M + H)+] and N-methylaniline [m/z = 108 (M + H)+], in 17% and 28% yields, respectively. Amines 
and/or imines were detected upon the photolysis of nitrosamines 3 and 4. 
 
A       B 
   
Figure 2. HPLC/MS isotopic abundances of nitrosamine reagent [M+H]+ (▲) and 18O-labeled 
nitrosamine product [(M+2)+H]+ (■) as a function of photolysis time of 1 (A) and 2 (B) with 18O2 in acetonitrile-d3. The sum of the isotopic abundance of the 2 peaks and [(M+1)+H]+ was normalized to 100%.  
 
5.2.3 Effects of Added Radical Scavenger Butylated Hydroxytoluene 
 Because Crumrine et al.15 found that the photolysis of nitrosamines leads to NO∙ and aminyl 
radicals where amine product formation was increased in protic solvents, we hypothesized that 
BHT scavenging of the aminyl radical by H-atom transfer agent will decrease the α-C–H 
abstraction reaction to imine 6. This is indeed what we find. In the presence of BHT and 18O2, UV 
photolysis of 3 was carried out for 1 h and followed by HPLC/MS. The formation of amine 5 
increased from 42% to 60% and the formation of imine 6 decreased from 24% to 2%. The result 
suggests that the aminyl radical arises following NO∙ release and rapidly abstracts a hydrogen atom 
in the presence of BHT. Because of the possible instability due to moisture, we next examined 




5.2.4 Photo-oxygen Exchange by Adventitious H218O is Ruled Out  
When the photolysis reaction was carried out in an 16O2-saturated atmosphere in CD3CN 
in the presence of <1% w/v H218O for 3 h, the 18O atom was found not to exchange into 
nitrosamines 1 or 2. Similarly, the 18O atom exchange did not occur with H218O addition in N2 
degassed photolysis experiments in the absence of 18O2. Thus, the involvement of H218O in the 
exchange of 18O can be ruled out. To provide further insight to the formation of these 18O labeled 
nitrosamines, we have conducted a study to explore whether the exchange process derived from 
singlet oxygen. 
 
5.2.5 Experiments with 18O-Labeled Singlet Oxygen (18O2) 
18O-Labeled singlet oxygen was generated by photochemical or chemical methods. 
Visible-light irradiation [metal-halide lamp with a cutoff filter (λ < 500 nm) as the light source] of 
0.2 mM SiPcCl2 or methylene blue in the presence of 1-4 (5 mM) was used in 18O2-saturated CHCl3 
solutions. We found no evidence for the exchange of an 18O-atom in the nitrosamines. Scheme 4 
shows that 18(1O2) was generated from a chemical source [18O–18O labeled naphthalene 
endoperoxide of N,N’-di(2,3-hydroxypropyl)-1,4-naphthalene dipropanamide (DHPN18O2)],50 
which also failed to exchange an 18O atom into 1. The thermal decomposition of DHPN18O2 was 
carried out in the presence of 1 in CH3CN/D2O buffer phosphate (2:1) at pD 7.4 and also in a 2-
phase CHCl3/D2O buffer phosphate (2:1) system at pH 7.4 with stirring for 1 h at 37 °C. Figure S6 
(Supporting Information) shows the HPLC/MS of 18O-labeled endoperoxide of DHPN18O2 before 
and after its thermal decomposition. Theoretical evidence that supports the reaction in Scheme 3 
is described next. 
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Scheme 4. Thermal decomposition of DHPN18O2 to generate 18(1O2) 
 
 
5.2.6 DFT Computed Bond Dissociation Energies 
DFT calculations were conducted to predict bond dissociation energies (BDE), excited 
state energetics, and geometries and energetics of the reagents and intermediates in the 
nitrosamine/O2 photoreaction.  
First, we discuss the N–N BDEs that have been computed. Table 2 shows that the BDEs 
are about 14-18 kcal/mol lower for 1 and 2 compared to 3 and 4. This is a telling result because 
the lower N–N BDEs of 1 and 2 do not result in greater loss of NO∙, but instead a greater propensity 
for 18O-photoexchange. Our BDE values are similar to previous theoretical studies for N–N BDEs 
of ~35 kcal/mol (when X is an aromatic substituent) and X–NH–NO ranging from 48 kcal/mol 
(when X is an alkyl substituent).51 Due to resonance, the aminyl radicals derived from the 
nitrosamines 1 and 2 (i.e. Ph2N∙ and Ph(Me)N∙) are stabilized and account for the lower the N–N 
BDE relative to the aliphatic aminyl radicals derived from 3 and 4. Nitrosamines 1 and 2 also have 
longer N–N bond lengths compared to 3 and 4 as anticipated for weaker N–N bonds. Table 2 and 
Figure 3 show our TD-DFT computed vertical electronic excitation energy from the ground state 
(S0) to the S1 and T1 states of nitrosamines 1-4 and 7. Our values are in fairly good agreement with 
previously reported experimental values.16 For example, for N-dimethylnitrosamine, the 




Table 2. Energetics and parameters of nitrosamines 1-4 with DFT and TD-DFT calculations 
 
nitrosamine BDE (kcal/mol) a N–N bond distance (Å) b S1 (kcal/mol) c T1 (kcal/mol) c 
1 28.6 1.35 71.9 48.4 
2 32.6 1.34 76.6 53.0 
3 47.8 1.32 79.3 55.6 
4 46.4 1.32 79.1 55.5 






5.2.7 Proposed Mechanism 
To assess the factors that underlie nitrosamine photochemistry in the presence of O2, three 
mechanistic aspects were considered. One emanates from the 18O exchange reaction of 
nitrosamines with O2 via hexaoxadiazocane and trioxazetidine intermediates that cleave apart, the 
second from unimolecular NO∙ release and formation of amine and/or imine products, and the last 
is the viability of the peroxy intermediates. 
(i) O-Atom Exchange. That the photoexchange occurs with 18O2 is viewed as evidence for 
a reaction with triplet nitrosamine. Assuming nitrooxide A is sufficiently long-lived, subsequent 
dimerization of the nitrooxide to yield the hexaoxadiazocane C with loss of O=18O can lead to the 
exchange of the oxygen atom label. Alternatively, but higher in energy, is the conversion of 
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nitrooxide A to trioxazetidine B, which is followed by the unimolecular collapse of the 
trioxazetidine to nitrosamine and oxygen.  
 (ii) Nitrosamine Photodecomposition. The aliphatic substituents on nitrosamine play a key 
role in facilitating the photodecomposition. α-C–H groups are labile to hydrogen abstraction by 
radicals and offer an explanation to the rapid photodecomposition of 3 and 4, and the slightly faster 
decomposition of 2 compared to 1 in our series. Oxygen-derived radicals would be expected to 
react with the nitrosamines and contribute to their decomposition. For example, nitrosamines16 
(and amines52) bearing α-C–H groups can more easily photodecompose than aromatic 
nitrosamines (and amines). Furthermore, dialkylaminium radical can react with an aliphatic 
nitrosamine via α-C–H abstraction leading to an alkylidenimine product.53 There are reports of 
nitrosamines losing NO∙ where the exciting wavelength modulates the NO∙ donor activity, where 
the aminyl radical can persist for longer periods from the S1 state.14,16 That NO∙ formation in 1 and 
2 is minor also argues for a triplet process. Expulsion of NO∙ occurs but is not the main reaction 
route of the aryl nitrosamines 1 and 2. It was interesting and unexpected that lower nitrosamine 
N–N BDEs correlate with the ease of O-atom photoexchange since the exchange nets an identity 
reaction not a N–N bond broken compound. 
(iii) Reactive Intermediates in the 18O Exchange Process. The mechanism in Scheme 3 is 
tentative and is based on of nitrosamines 1 and 2 and the dimerization of their corresponding 
nitrooxides in preference to the unimolecular cyclization of nitrooxides. Computations indicate 
high-energy barriers for the nitrooxide dimerization to hexaoxadiazocane C and for the conversion 
of nitrooxide A to trioxazetidine B. Thus, photochemical interconversions would be necessary to 
overcome the high barriers. We note there are similarities of our work to the previous literature. 
That is, nitrooxide A bears similarity to the nitrosooxide, an intermediate formed in the reaction 
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of nitrenes with 3O2.40-49,54,55 Relatedly, the trioxazetidine B is reminiscent of the 1,2,3,4-
dioxadiazete, which along with its radical cation (cycloN2O2 species) have been postulated in gas-
phase ion–molecule reactions.56 The dimerization of nitrooxide A to hexaoxadiazocane C is 
reminiscent of the coupling of a carbonyl oxide yielding a dimeric benzophenone peroxide57 and 
also nitrosooxide yielding a tetraoxadiazine.27 Furthermore, the photocyclization of A and B is 
similar to that reported for the photocyclization of nitrosooxide to dioxaziridine,35,42,58 where 18O 
labeling also showed aryl dioxaziridines arise in the photooxidation of aryl azides (λ > 350 nm) 
using 18O2 gas by photocyclization of the aryl nitrosooxide.40,41  
In summary as described above, a photochemical process that transposes an 18O label from 
molecular oxygen 18O2 was seen for nitrosamines 1 and 2, but not for 3 and 4. The 18O atom source 
was found not to be from moisture based on control photolysis experiments with 18O-labeled H2O. 
Thermal or visible-light sensitized production of singlet 18O2 to give 18O-labeled nitrosamine was 
not observed. In these reactions, physical quenching of 1O2 to 3O2 is likely a key pathway. An 
ordinary [2 + 2] cycloaddition of 1O2 to the nitrosamine N=O bond is not operating as a means to 
reach the trioxazetidine and scramble the 16O and 18O atoms.  
 
5.3 Conclusion 
Four nitrosamines 1-4 were irradiated in the presence of 18O-labeled molecular oxygen gas 
to examine a substituent dependence in the O-atom exchange process. Di- and monophenyl 
nitrosamines 1 and 2 are more photostable than the dialkyl nitrosamines 3 and 4. Nitrosamines are 
generally recognized not to be good sources of NO∙,23,59 even under N2 atmosphere, due to the 
formation of by-products. Whether triplet sensitization of nitrosamines is also a viable strategy to 
reach the nitrooxide is a question that we are also exploring. The formation of non-nitrosamine 
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products, such as nitroamine in photooxidation reactions is currently being explored. Another 
question yet to be addressed is related to possible chemiluminescence from the trioxazetidine (by 
analogy to 1,2-dioxetanes).60,61 Time-resolved IR methods62-65 would also provide insight into the 
mechanism. Lastly, the discovery of an oxygen exchange route in nitrosamine photochemistry and 
the formation of peroxy intermediates derived from this reaction is described here and may provide 
a clue to new factors significant in nitrosamine phototoxicity. 
 
5.4 Experimental Section 
5.4.1 Materials and Methods 
Diphenylamine, N-methyl-N-(p-tolyl) amine, silicon phthalocyanine dichloride (SiPcCl2), 
methylene blue, butylated hydroxytoluene (BHT), K2Cr2O7, CH3CN, CHCl3, CDCl3, H218O 
(96.9%), 18O2 gas (99% 18O) from a gas cylinder, and N-nitrosodiphenylaniline 1, N-nitroso-N-
methylaniline 2, N-butyl-N-(4-hydroxybutyl)nitrosamine 3, N-nitrosodiethylamine 4 were 
purchased commercially. (Caution: nitrosamines are carcinogenic). 
Positive ion mode electrospray ionization mass spectrometry data were collected as 
previously described.66 The analysis was done by direct injection to a mass spectrometer with a Z-
spray atmospheric pressure ionization source. Samples were dried and reconstituted in acetonitrile 
prior to injection into the mass spectrometer. HPLC-MS/MS refers to liquid chromatography 
coupled to an electrospray ionization tandem mass spectrometry instrument67 that was used. 
HPLC/MS data were collected as has been described in our previous work.68 NMR data were 
recorded on an instrument operating at 400 MHz for 1H NMR and 100.6 MHz for 13C NMR. UV-
visible and GC/MS data were also collected. Micromass software was also used to generate 




5.4.2 18O-Photoexchange Reactions 
Photooxidations were carried out in a 3-mL sealed glass vial at 27 °C with periodic 18O2 
bubbling and irradiation with two 400-W metal halide lights or two 500-W tungsten lights. 
Experiments were conducted in 1-mL CHCl3 or CH3CN solutions of 1 mM or 5 mM 1-4. Prior to 
photolysis, one of two methods was used to introduce 18O2 gas: (i) CHCl3 solutions were frozen 
and thawed in liquid N2 and kept under vacuum, then the system was connected to an 18O2 gas 
cylinder, and the system was kept closed during the photolysis; or (ii) CH3CN solutions were 
sparged with N2 for 15 min and then 18O2 gas for 5 min. During the photolysis, at 30-min intervals, 
samples were sparged with 18O2 gas for 3-min periods. CHCl3 contains trace ethanol as a stabilizer, 
which was not removed. The results were reproducible and nearly identical in either CHCl3 or 
CH3CN solutions. Reaction mixtures were analyzed by HPLC/MS and HPLC-MS/MS. For the 
HPLC/MS, the column used for 1-4 was a 2.1 mm × 30 mm, 3.5 μm SB-C18 column. For the 
HPLC-MS/MS, the column used for 1 and 2 was a 25 cm × 2.1 mm, 5 µm Supelcosil LC18-S 
column, and for 3 and 4 was a 25 cm × 4.6 mm, 5 µm C18 Gemini column. 
 
5.4.3 UV Photolysis of N-nitrosodiphenylaniline (1) 
HPLC/MS: tR = 5.48 min; HRMS (+ESI) calcd for labeled C12H11N218O = 201.0938, found 
201.0958; calcd unlabeled C12H11N2O = 199.0871, found 199.0872. When followed by HPLC-
MS/MS, peaks were observed for 1 (m/z = 199) and 18O-exchanged 1 (m/z = 201) at 24.69 min, 
and diphenylamine (m/z = 170) at 26.51 min. Spiking a commercial sample of diphenylamine led 




5.4.4 UV Photolysis of N-nitroso-N-methylaniline (2) 
HPLC/MS: tR = 3.91 min; HRMS (+ESI) calcd for labeled C7H9N218O = 139.0757, found 
139.0755; calcd unlabeled C7H9N2O = 137.0715, found 137.0724. When followed by HPLC-
MS/MS, peaks were observed for N-methylaniline (m/z = 108) at 4.81 min, 2 (m/z = 137) and 18O-
exchanged 2 (m/z = 139) at 12.69 min. 
 
5.4.5 UV Photolysis of N-butyl-N-(4-hydroxybutyl)nitrosamine (3) and nitrosodiethylamine 
(4) 
When followed by HPLC-MS/MS, peaks were observed for parent 3 and 4, but not 18O-
exchanged 3 and 4. The photolysis of 3 led to an imine 4-((1-hydroxybutyl)imino)butan-1-ol or 
isomer [m/z = 144 (M + H)+] at 5.87 min and 4-(butylamino)butan-1-ol [m/z = 146 (M + H)+] at 
7.26 min. The photolysis of 4 led to diethylamine (m/z = 74) at 3.92 min.  
 
5.4.6 Photochemical and Chemical Generation of Singlet Oxygen [18(1O2)] 
Experiments were conducted in 1-mL CDCl3 or CH3CN solutions of 1 mM or 5 mM 1-4. 
The experiments for a photochemical source of 18(1O2) used a photosensitizer, 0.1 mM SiPcCl2 or 
methylene blue, in which samples were irradiated through a cutoff filter (λ < 500 nm) solution of 
0.2 M K2Cr2O7 in 0.5% v/v H2SO4. The experiments for a chemical source of 18(1O2) used an 18O-
18O labeled endoperoxide [N,N’-di(2,3-dihydroxypropyl)-1,4-naphthalene dipropanamide 
(DHPN18O2)] that was synthesized as described previously.7 
 
5.4.7 Computational Methods 
Calculations were performed with Gaussian 09 (revision D.01)69 and visualized with 
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Gaussview 5.0.70 Geometries were optimized with unrestricted ωB97X-D, which includes 
empirical dispersion71 along with the 6-311+G(d,p) basis set. These calculations yielded results in 
reasonably good agreement with CCSD(T) based on the reaction of ethene with 1O2.72 The 
energetics are reported as the thermal enthalpies. BDEs were determined by UB97X-D/6-
311+G(d,p) calculations of optimized geometries of 1-4 and the corresponding aminyl radicals and 













wavelength a sensitizer b 
irradiation 
time (h) solvent gas MW 
mass found in spectra c 
[M+H]+ [(M+2)+H]+ 






none chloroform 18O2 199 201 
none acetonitrile 18O2 199 201 
none acetonitrile 16O2 199 - 
none acetonitrile d 16O2  199 - 
none acetonitrile d N2 199 - 
2 





visible SiPcCl2 chloroform 16O2 137 - 
visible  SiPcCl2 chloroform 18O2 137 - 
visible  methylene blue chloroform 18O2 137 - 
UV and vis none chloroform 18O2 137 139 
UV and vis none acetonitrile 18O2 137 139 
UV and vis none acetonitrile 16O2 137 - 
UV and vis none acetonitrile d 16O2  137 - 
UV and vis none acetonitrile d N2  137 - 
3 UV and vis none 3 chloroform 18O2 174 175 - none acetonitrile 18O2 175 - 




  Figure 3. HPLC/MS data of relative mass isotopic abundance of [M+H]+ (grey), [(M+1)+H]+ 
(light grey), and [(M+2)+H]+ (dark grey) peaks prior to and after photolysis of nitrosamines 1-4 
with 18O2 in acetonitrile. The sum of the isotopic abundance of the three peaks was normalized to 100%. 
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 Figure 4. HPLC-MS/MS analysis of nitrosamine 1 before (A) and after (B) photolysis with 18O2 in chloroform. The data show unlabeled 1 ([M+H]+, m/z = 199) and a +2 Da mass increase due to 
the exchange of an 18O atom ([(M+2)+H]+, m/z = 201). A peak corresponding to an acetonitrile 




 Figure 5. HPLC-MS/MS of products formed after 3 h photolysis of nitrosamine 1 with 18O2 in chloroform. Ion selection analysis for (A) nitrosamine 1 (m/z = 199) and (B) N,N-diphenylamine 
(m/z = 170). MS/MS fragmentation of peak for (C) 18O-labeled nitrosamine 1 at 24.69 min and (D) 
N,N-diphenylamine at 26.51 min.  
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  Figure 6. HPLC/MS analysis of nitrosamine 1 before (A) and after (B) photolysis with 18O2 in acetonitrile after 3 h. UV-visible detection is shown at 280 nm. For spectrum B, the peak at 
tR = 5.48 min corresponds to nitrosamine 1 and peak at tR = 5.71 min corresponds to N,N-diphenylamine. The other peaks in spectrum B are unidentified products.  
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  Figure 7. HRMS data of 1 after photolysis with 18O2 in chloroform (A), showing fragment ions of 199 m/z (B), and 201 m/z (C).   
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 Figure 8. HPLC-MS/MS of 18O-labeled N,N´-di(2,3-hydroxypropyl)-1,4-naphthalene 
dipropanamide endoperoxide (DHPN18O2) before (A) and after (B) thermal decomposition to chemically generate 18(1O2) and N,N´-di(2,3-dihydroxypropyl)-1,4-naphthalene dipropanamide and (C) of nitrosamine 1 upon exposure to DHPN18O2.  ESI+/MS of DHPN18O2 before (D) and after (E) thermal decomposition to chemically generate 18(1O2) and of (F) nitrosamine 1 upon exposure to DHPN18O2. DHPN18O2 did not introduce an 18O atom into nitrosamine 1.
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 Figure 9. HPLC-MS/MS analysis of nitrosamine 2 before (A) and after (B) photolysis with 18O2 in chloroform. The data show unlabeled 2 ([M+H]+, m/z = 137) and a +2 Da mass increase due to 
the exchange of an 18O atom ([(M+2)+H]+, m/z = 139). A peak corresponding to an acetonitrile 
adduct is seen at m/z = 178. 
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 Figure10. HPLC-MS/MS of products formed after 3 h photolysis of nitrosamine 2 with 18O2 in chloroform. Ion selection analysis for (A) nitrosamine 2 (m/z = 137) and (B) N-methylaniline (m/z = 108). MS/MS 
fragmentation of peak for (C) 18O-labeled nitrosamine 2 at 12.69 min and (D) N-methylaniline at 4.81 min.  
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 Figure 11. HPLC/MS analysis of nitrosamine 2 before (A) and after (B) photolysis with 18O2 in acetonitrile after 3 h. UV-visible detection is shown at 280 nm. For spectrum B, the peak at tR = 3.92 min corresponds to nitrosamine 2 and peak at tR = 4.51 min corresponds to N-methylaniline.    
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  Figure 13. HPLC-MS/MS of products formed after 1 h photolysis of nitrosamine 3 with 18O2 in chloroform. Ion selection analysis for (A) nitrosamine 3 (m/z = 175), (B) 4-(butylamino)butanol 
(m/z = 146), and (C) a tentative assignment of 4-(butylimino)butanol (m/z = 144). MS/MS scan of 
peaks found (D) nitrosamine 3 at 16.46 min, (E) 4-(butylamino)butanol at 7.26 min, and (F) 4-
(butylimino)butanol or isomer at 5.87 min. The peak at 20.60 min in spectrum A and peak at 16.31 
min in spectrum C, are unidentified products. MS/MS data show unlabeled 3 ([M+H]+, m/z = 175). 









 Figure 14. HPLC/MS analysis of 3 before (A) and after (B) 30 min photolysis with 18O2 in acetonitrile. HPLC trace of 3 before (C) and after (D) 30 min photolysis with 18O2 in acetonitrile.  UV-visible detection was conducted at 280 nm. The MS data show unlabeled 3 ([M+H]+, m/z = 








 Figure 15. HPLC-MS/MS of products formed after 1 h photolysis of nitrosamine 3 with 18O2 in chloroform in the presence of BHT. Ion selection analysis for (A) nitrosamine 3 (m/z = 175), (B) 
4-(butylamino)butanol (m/z = 146), and (C) a tentative assignment of 4-(butylimino)butanol (m/z 
= 144). MS/MS scan of peaks found (D) 3 at 16.39 min, (E) 4-(butylamino)butanol at 7.20 min, 









 Figure 16. HPLC-MS/MS of products formed after 1 h photolysis of nitrosamine 4 with 18O2 in chloroform. Ion selection analysis for (A) nitrosamine 4 (m/z = 103), (B) diethylamine (m/z = 74). 
MS/MS scan of peaks found (C) nitrosamine 4 at 13.42 min, and (D) diethylamine at 3.92 min. 
MS/MS data show unlabeled 4 ([M+H]+, m/z = 103). A +2 Da mass increase for 18O-labeled 4 was 









 Figure 17. HPLC/MS analysis of 4 before (A) and after (B) 30 min photolysis with 18O2 in acetonitrile. HPLC trace of 4 before (C) and after (D) 30 min photolysis with 18O2 in acetonitrile.  UV-visible detection is shown at 280 nm. The MS data show unlabeled 4 ([M+H]+, m/z = 103). A 








 Figure 18. Absorption spectra of nitrosamines 1 (solid black), 2 (solid grey), 3 (dotted black), 
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Chapter 6. Literature Review of the Use of Singlet Oxygen to Synthesize Natural Products 
and Drugs 
  
6.1 Introduction and Background 
This Review discusses photogenerated singlet oxygen (1O2) in synthetic organic chemistry. 
Even though singlet oxygen is a short-lived metastable excited state of molecular oxygen, it is a 
practical reagent for compound oxidation and can form carbon-oxygen and heteroatom-oxygen 
bonds. The motivation for the Review is to encourage its further use in the synthesis of natural 
products and drugs. 
Historically, 1O2 showed diffusible properties with photosensitization as a convenient 
method for its production in the Foote-Wexler reaction 50 years ago.1,2 Since this time, 1O2 is 
established for its ability to oxidize organic and biological compounds,3-11 or be used in synthesis.   
In the 1980s, reports emerged on the use of singlet oxygen in the synthesis of natural 
products. The use of 1O2 in organic synthesis was pioneered12-14 and routes to natural products by 
1O2 began to be classified as biomimetic. While singlet oxygen’s frequency in the synthesis of 
natural products has increased in the past 10 years, it is still a relative newcomer. 
Scheme 1 shows synthetically useful 1O2 reactions for generating oxygenated compounds, 
including the formation of endoperoxides from Diels-Alder reactions, dioxetanes from [2 + 2] 
cycloadditions, hydroperoxides from alkenes and phenols, sulfoxides from sulfides, and phosphine 
oxides from phosphines.15-22 Not only is the chemical trapping of 1O2 easy (Scheme 1), its 
generation is also straight forward (Scheme 2).  
Scheme 2 shows two methods that give rise to 1O2, although the Review focuses 








(Scheme 2A), such as H2O2 with NaOCl23 or the use of peroxides [arene endoperoxides,24-27 
hydrotrioxides,28-31 dihydroperoxides,32,33 potassium monoperoxysulfate (KHSO5),34-36 
dimethyldioxirane,37 ozone/heterocycle adducts with pyrroles, oxazoles, and imidazoles,38 or 
triphenylphosphite ozonide, cyclo-(PhO)3PO3].39,40 Such peroxides are oxidants themselves that 
can react with the substrates directly or have poor functional group tolerance, which are synthetic 
concerns. But these peroxide reagents can be eliminated in the second route. 
The second route is the photosensitized production of 1O2 (Scheme 2B).41 This oxygen-
dependent photosensitization reaction is not only useful in organic synthesis, it is extremely 
common in nature. The route is appealing since it only requires visible light, oxygen and a 
sensitizer to produce 1O2. Light excites the sensitizer and not the substrate. Thus, the process is 
wavelength-selective, where narrow and broad-band light sources can be used.42 Furthermore, 
fabricated capillary reactors that run on miniature light-emitting diodes (LEDs) have advantages 
to batch reactors. Small reactors with low-energy long wavelengths are more appealing than large 


























Scheme 2. Generation of singlet oxygen 
 
 
6.2 Scope of the Review  
The Review is intended to be of interest to synthetic organic chemists. Only modest 
information is known for singlet oxygen’s success in organic synthesis applied to complex targets 
or the use of 1O2 in flow synthesis. No comprehensive coverage exists for 1O2 in the organic 
synthesis of natural products and drugs. The Review has been organized into two sections 
(Sections 6.3 and 6.4).  
In Section 6.3, natural products or related compounds are discussed where singlet 
oxygenation is a key step in their biomimetic synthesis. Because the synthesis of butenolides43-47 
and trioxane antimalarial drugs48-59 using 1O2 chemistry has been reviewed, our description of 
these topics will be confined to Section 5. Similarly, because there are reviews on 1O2 in physical-
organic chemistry,60-63 this literature will not be explicitly covered. Physical and environmental 
chemistry aspects of 1O2 will also not be covered due to preexisting reviews.64-67  
In Section 6.4, 1O2 flow photoreactors and their success in synthesis will be summarized 
in an effort to help validate them. Previous reviews on flow photoreactors that have selected 








Section 5 exclusively covers 1O2 flow photoreactors in synthesis. “Flowing” 1O2 generators such 
as the chemical oxygen-iodine laser (COIL)71-75 with supersonic I2/O2 mixing will not be covered 
because there is no overlap with organic synthesis. Extensive studies have been carried out with 
direct substrate photolysis in flow reactions,76-83 which will also not be covered. Lastly, the Review 
will emphasize the interplay between basic (Section 6.3) and applied research (Section 6.4) to 
further establish 1O2 in the synthesis of targets with industrial scale syntheses in mind. 
 
6.3 Singlet Oxygen in Synthesis  
6.3.1 Background 
In this section, we provide accounts of 1O2 in batch reactions for the synthesis of natural 
products and drugs. Schemes 4-53 show the extent of complex targets synthesized to date using 
1O2. There are reports of tandem additions of 1O2 molecules in the literature.84-96 Many studies 
formed peroxide cycloadducts as intermediates, which often rearranged or were reduced to more 
stable groups. Common reducing agents used are thiourea, dimethylsulfide and 
triphenylphosphine. As we will see, tetraphenylporphyrin (TPP), rose bengal (RB) and methylene 
blue (MB) are the most common sensitizers (Sens) in homogeneous solutions.97-101  Irradiation of 
Sens0 causes Sens* to efficiently produce singlet oxygen (type II) and trace amounts of oxygen 
radicals (type I) (Scheme 3), the latter is responsible for photobleaching over long irradiation 
times. Heterogeneous sensitizers are diphasic with two appeals (pun intended), they are generally 
less prone to photobleaching compared to homogeneous sensitizers102-106 and they are easy to 
separate from solution after reaction; examples include, polymer-supported RB, secoporphyrazine 








substrate absorbs visible light to generate 1O2 which reacts on itself; three examples are described 
in Section 4.11 in the context of natural products and drug synthesis.  
 
Scheme 3. Schematic of type I/II photooxidation reactions 
 
 
In the context of synthesis, there are caveats unique to singlet oxygen chemsitry: (i) An 
inverse relationship exists between temperature and rate, where 1O2 often adds more rapidly at low 
temperature (many 1O2 reactions are under entropy-control).121-124 (ii) Peroxide product stabilitites 
vary and low-temperature NMR spectroscopy is beneficial for detection in crude reaction mixtures. 
Furthermore, deuterated NMR solvents show duplicity with 1O2 in synthesis for in situ monitoring 
and faster reaction rates. (iii) The rate of 1O2 reactions is faster in deuterated solvents due to longer 
1O2 lifetimes (τ ∆); for example, compare toluene-d8 (τ ∆ = 280 µs) vs toluene (τ∆ = 29 µs), and 
CDCl3 (τ ∆ = 7.0 ms) vs CHCl3 (τ ∆ = 230 µs).125,126 In contrast, protic solvents produce the shortest 
1O2 lifetimes due to facile deactivation by O–H vibrational quenching to ground state 3O2. (iv) 
Some 1O2 is wasted through substrate physical quenching. The total rate constants (kT) of 1O2 of a 
compound is known to be the sum of the chemical quenching rate constant (kr) and the physical 
quenching rate constant (kq), where reactions can be efficient (kr ≈ kT) or inefficient (kq ≈ kT). The 
latter case is observed with amines, which deactivate 1O2 by charge-transfer quenching (107 to 108 








generating oxygen radicals.131 (v) In terms of selectivity, 1O2 reacts preferentially with compounds 
of higher nucleophilicity owing to singlet oxygen’s electrophilicity.132-134 For example, the kT of a 
tetrasubstituted diene (2,5-dimethyl-2,4-hexadiene)135 is ~100 fold greater than a disubstituted 
diene [(E,Z)-2,4-hexadiene] so the former site is selectively reacted as is relevant in the first 
example in Section 6.3.2, the synthesis of endoperoxide natural products. 
 
6.3.2 Endoperoxides 
We have located 3 studies; first, a 2002 report describes the RB-sensitized 
photooxygenation of a trisubstituted diene selectively in the presence of a trisubstituted alkene to 
furnish a mixture of diastereomeric endoperoxides. The photooxidation of triene 1 was followed 
by a reaction with diazomethane leading to endoperoxides 2 and 3 in 40% yield (Scheme 4).136 To 
reach 2 and 3, the synthesis was 18 steps in length with a total yield of 2.8%. Based on the 
assignment of diastereomeric (3R,6S,8R,10R)-2 and (3S,6R,8R,10R)-3, the natural product 4 is 
tentatively assigned as 3S,6R,8S,10R. Carboxylic acid derivatives of 2 and 3 are known to have 










Scheme 4. Synthesis of marine sponge endoperoxide isomers 
  
 
Second, a 2002 report describes the RB-sensitized photooxidation of a 1.8:1.0 ratio of 
(3E,5E):(3Z,5E) dienes 5 (Scheme 5),138 to form diastereomeric endoperoxides 6 and 7 (also in a 
ratio of 1.8:1.0) and a 45% combined yield. Four additional steps furnished the natural product 
(±)-6-epiplakortolide E 8, which bears a flexible phenyl-terminated polymethylene chain. It is not 
obvious how 6 and 7 form in the same 1.8:1.0 ratio since it is expected that the 1O2 [2 + 4] 
cycloaddition is less feasible due to distortion of the 3Z,5E diene to reach the s-cis geometry. For 
example in 2,4-dimethyl-2,4-hexadienes, [2 + 4] addition is favored for E,E, but not E,Z where the 










Scheme 5. Synthesis of (±)-6-epiplakortolide E 
 
 
Third, an approach reported in 1999 features a TPP-sensitized photooxidation of 9 and 14 
to give hydroperoxides 10 and 15 regioselectively in 62% and 69% yields, respectively (Scheme 
6A and 6B).140,141 The regioselectively was the result of 1O2 addition to the Z-allylic alcohol with 
H-bonding. The hydroperoxides reacted with DTBN causing a peroxyl radical Schenck 
rearrangement142 to hydroperoxides 11 and 16. A series of additional steps with hydroperoxide 11 
and 16 afforded chondrillin (+)-12 and (-)-17, and plakorin (+)-13 and (-)-18. Chondrillin has 
shown antitumor activity against P388 leukemia cells, and plakorin is an activator of sarcoplasmic 
reticulum Ca(II)-ATPase.143 We also note that stereoselective synthesis of (Z)-3-tributylstannyl-2-
alkenyl hydroperoxides from the 1O2 ‘ene’ reaction of allylstannanes144-147 have also yielded 














Singlet oxygen chemistry is an efficient way to reach highly oxygenated compounds, such 











Singlet oxygen acts in some way as a liver enzyme (cytochrome P450) by processing 
hydrophobic compounds to increase their water-solubility by introducing hydroxyl groups. A 1998 
report described the TPP-sensitized photooxidation of dioxolane 21 which gave hydroperoxide 22 
in 95% yield (Scheme 7).148 Hydroperoxide 22 was reduced with thiourea to form alcohol 23, and 
subsequent reactions led to DL-vibo-quercitol 24 and DL-talo-quercitol 25. There are literature 
examples of highly oxygenated compounds, such as pinitol, cyclitols, and polyols synthesized by 
other oxidation methods, e.g., epoxidation, osmylation, and ozonolysis.148-150 Relatedly, 1O2 
reactions have been previously reported for the synthesis of conduritols,151-157 and proto-quercitol 
and gala-quercitol as is discussed in the next example.158  
 









A synthesis reported in 1997 used the TPP-sensitized photooxidation of 1,4-
cyclohexadiene 26 to give hydroperoxide 27, which upon addition of a second 1O2 molecule led 
to hydroperoxy endoperoxides 28 and 29 in 72% yield (88:12 ratio) (Scheme 8).158 The reduction 
of peroxides 28 and 29 with LiAlH4 was followed by protection of the alcohol group with acetic 
anhydride affording triacetates 30 and 32, respectively. Further reactions led to DL-proto-quercitol 
31 and DL-gala-quercitol 33. In a related report in 2010, hydroperoxide 28 was found to afford 
oxazolidinone 34, leading to DL-gala-aminoquercitol 35.159  
 









From 2014, a report described the TPP-sensitized photooxidation of cyclohexa-1,3-diene 
36 (Scheme 9).160 The addition of 1O2 to 36 occurred in the expected [2 + 4] pathway leading to 
endoperoxide 37, which was reduced and acetylated to afford diacetate 38, and two additional 
steps led to DL-tetrol 39. In a related report in 2014,161 other carbasugars such as DL-pentaol 40 
arise from endoperoxide 28 following a similar strategy.  
 
Scheme 9. Synthesis of a DL-tetrol and a DL-pentaol  
  
 
A 2013 paper describes the TPP-sensitized photooxidation of 4,5-dimethylenecyclohex-1-
ene 41 (Scheme 10),162 where the tandem addition of three 1O2 molecules was observed. Singlet 
oxygen first added to 41 by a [2 + 4] cycloaddition to form endoperoxide 42 in 86% yield. A 








by another [2 + 4] cycloaddition. As can be seen, resulting tris peroxides 43 and 44 contain a high 
degree of oxygenation. In addition to the evidence for 43 and 44 from NMR spectroscopy, X-ray 
crystal data were also obtained for 44. The reduction of 43 was carried out with thiourea. The 
alcohol groups reacted with acetic anhydride in pyridine to form triacetate 45 in 82% yield. 
Isomeric heptols DL-46 and DL-47 were then formed in further reactions. Other reports also show 
that hydroperoxides are efficiently prepared by reacting cyclohexa-1,4-dienes with 1O2 in an ene-
reaction.163-165  
 
Scheme 10. Synthesis of isomeric heptols  
 
 
In 2011, a report appeared describing the TPP-sensitized photooxidation of 2-(6-
acetoxycyclohex-3-en-1-yl)ethyl acetate 48 to form hydroperoxide 49 and enone 50 in 72% and 
14% yields, respectively (Scheme 11).166 Reduction and acetylation of hydroperoxide 49 followed 
by a series of reactions afforded 5a-carba-6-deoxy-α-DL-galacto-heptopyranose (51) and 5a-













Lastly, a 2003 report described the TPP-sensitized photooxidation of trans-8-(acetyloxy)
bicyclo[4.2.0]octa-2,4-dien-7-yl acetate 53 which gave endoperoxide 54 in 70% yield (Scheme 
12).167 Reduction and acetylation of 54 led to tetraacetate 55 in 73% yield, and further reactions 















Even though 1O2 is a high-energy species, epoxide products are tolerant of it. Four 
preparative examples of 1O2 for reaching epoxide-containing natural products are described. First, 
a 2005 paper describes the MB-sensitized photooxidation of diastereomeric bicyclo[4.2.0]octanes 
57 and 60 separately gave endoperoxides 58 and 61, respectively in 69% and 72% yield (Scheme 
13).168 Endoperoxides 58 and 61 were then isomerized with RuCl2(PPh3)3 using Noyori’s method 
to the diepoxides, elysiapyrones A 59 and elysiapyrones B 62 in 68% and 50% yields, respectively. 










Scheme 13. Synthesis of elysiapyrone A and B 
 
 
Secondly, a 2015 paper describes the MB-sensitized photooxidation of diene 63 which 
gave endoperoxide 64 selectively in 92% yield (Scheme 14).170 Endoperoxide 64 was converted 
to diepoxide 65 by treatment with DIBAL, followed by acetic anhydride and DMAP, and in a 
subsequent step by Noyori’s ruthenium (II) catalytic method. Seven additional reactions then led 










Scheme 14. Synthesis of (±)-limonin 
 
Third, a 1994 report described the TPP-sensitized photooxidation of a mixture of fusicocca-
2(6)-3-diene 67 and fusicocca-2,5-diene 68 (ratio 2:3) (Scheme 15).171 Attack of singlet oxygen 
on the cyclopentadiene ring of 67 and 68 occurred forming endoperoxides 69 and 70. Upon 
warming, rearrangements of endoperoxides 69 and 70 proceed to diepoxide and epoxy ketone 
products. Namely, 69 led to fusicogigantepoxide 71 and fusicogigantone A 72, and 70 led to 
2α,3α:5α,6α-fusicogigantepoxide B 73 and 2α,3α-fusicogigantone B 74. NMR spectroscopy was 
used to help deduce the structures and X-ray data were collected for 71. Dienes 67 and 68 are 
plausible but not yet identified as natural precursors to reach 71-74 by singlet oxygenation. Studies 
of the rearrangement mechanism of 1,4-endoperoxides to 1,2:3,4-diepoxides have been 








also been successfully carried out with spiro[2,4]heptadiene.173 Furthermore, a photooxidation 
strategy was successful in the synthesis of the natural product senepoxide.174 
 
Scheme 15. Synthesis of fusicogigantepoxides and fusicogigantones  
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Fourth, a 2014 paper describes the RB-sensitized photooxidation of furan 75 in the 
presence of diisopropylethylamine (DIPEA) (Scheme 16).175 Preferential base abstraction of the 
left-hand bridgehead proton of the endoperoxide causes its decomposition by O–O bond 
heterolysis to butenolide 76. The early finding on the furan mechanism of forming two C–O bonds 
and breaking of an O–O bond to reach butenolide is interesting,176 which has been exploited to 
reach other butenolide and spiroketal natural products (as mentioned in Section 3).43-47 
Paradoxically, tertiary amines (such as DIPEA) physically quench 1O2 yet is essential for the base 
abstraction process. X-ray crystallographic data were also collected for 76. The preparation of four 
additional triptolide derivatives was accomplished, for an evaluation against ovarian (SKOV-3) 
and prostate (PC-3) cancer cells showing the activity depends critically on the D ring in these 
structures.  
 











6.3.5 Tropones and Tropolones 
Tropones and tropolones are widely seen in nature and represent highly oxygenated natural 
products. We have located four studies that use or form tropones and tropolones; first, a 2001 
report described the hematoporphyrin-sensitized photooxidation of atropisomers of (-)-
isocolchicine (78/79) which led to diastereomeric endoperoxides 80/81 and 82 in 54% and 8% 
yield, respectively (Scheme 17).177 Preferential anti addition of 1O2 to (M,7S)-(-)-78 atropisomer 
is due to molecule twisting negating the steric interactions from the benzenoid ring led to 80/81 as 
major endoperoxide products. Endoperoxides 80/81 and 82 were separated by column 
chromatography, in which the latter was favored (ratio of 80/81:82 was 7:1). Further synthetic 













Second, a 1997 paper described the reaction (-)-colchicine 84 with 1O2 to reach 
endoperoxide 85 (Scheme 18).178 This reaction has high regio- and facial selectivity due to the 
importance of sterics and hydrogen bonding of the acetamide N–H with 1O2. Endoperoxide 85 was 








or androbiphenyline (88) via the 4-membered ring lactone 86. Allo-colchicinoids, 87 and 88, are 
responsible for cell growth and tubulin polymerization inhibition,179 but until this synthetic work, 
preparative photooxidations of helimers were largely neglected to reach natural product targets. 
Direct photolysis studies in the last few years has also shown the virtues of using helimers in 
synthetic applications.180  
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Third, a 2006 report on the TPP-sensitized photooxidation of a dioxin-fused 
cycloheptatriene (89) was found to produce tricyclic endoperoxide 90 in 94% yield (Scheme 
19).181 Treatment of 90 with thiourea led to O–O bond reduction to tropolone 91 or other tautomers 
92-94 which bear some similarity to the natural product colchicine 84. Tropone endoperoxide 90 
releases 1O2 in a reverse Diels-Alder reaction forming starting material 89, in a similar fashion to 
naphthalene and anthracene endoperoxides which are storage pools to get back 1O2.182-184 Previous 
reports have also shown the photooxidations of benzotropones give endoperoxides that are stable 
at low temperatures.185-187 Encouragingly, benzotropones possess carbonic anhydrase isoenzymes 
inhibition properties.188 
  




Fourth, a 1991 report described the MB-sensitized photooxidation of clavukerin A 95 with 
pyridine in methanol which led to hydroperoxide 96 in 79% yield (Scheme 20).189 Hydroperoxide 
96 was treated with acetyl chloride in pyridine giving the acetyl peroxide, which underwent a 








protonation that can be explained by 1,2-neighboring group induction from the methyl center with 
ring opening to the tetrahydrotropones, for (±)-clavularin A 98 and (±)-clavularin B 99 in a 9:1 
mixture. Other than tropones and tropolones,190 natural products containing multiple rings 
common,191 as we will see next. 
 
Scheme 20. Synthesis of (±)-clavularin A and B 
 
 
6.3.6 Polycyclic Ethers and Polyols 
There have been reports in the synthesis of polycyclic ethers and polyols featuring [2 + 4] 
1O2 cycloaddition strategies. A 1999 report describes brevetoxin A 104 in which a key step was a 
TPP-sensitized photooxidation of the diene site of 100 (Scheme 21).192 This led to the formation 
of a diastereomeric endoperoxides 101. Reduction of the O–O bond of 101 with aluminum 
amalgam in THF/H2O led to the formation of diastereoisomeric diols 102 and 103 in a 1:1 ratio in 
58% yield over two steps. Additional steps in the synthesis lead to 104. Such polycyclic ethers and 
biomimetic pathways to reach them have been of interest due to their therapeutic and toxic 













Recently, a 2014 report described the RB-sensitized photooxidation of furan 105 followed 
by reaction in pyridine with DMAP and acetic anhydride at led to butenolide 106 in 76% yield 
(Scheme 22).195 Desilylation of butenolide 106 with tetrabutylammonium fluoride followed by a 








in 20% and 60% yields, respectively. Compounds 107 and 108 that arose from a furan precusor 
have potential synthetic utility as building blocks of polycyclic ether natural products.196-199 
 




In a different approach, one variation of the furan photooxidation topic is its substitution 
with a silyl group. A 1997 report described the TPP-sensitized photooxidation of 
trimethylsilylfuran 109 (Scheme 23).200 Here, the reaction involved an intramolecular silyl 
migration201 leading to butenolide 110 in 95% yield. Further steps were then required to reach 









Scheme 23. Synthesis of milbemycin E 
 
 
A paper 2007 reported the synthesis of the C29-C46 subunit I (116) of oasomycin A 117, 
in which one step included the RB-sensitized photooxidation of oxazole 112 (Scheme 24).202 Here, 
singlet oxygen was taken up by the oxazole site in 112. The reaction was a 1O2 [2 + 4] cycloaddition 
and not a [2 + 2] cycloaddition, as was previously deduced by singlet oxygen 18O-tracer studies 
with oxazoles.203 The intermediate endoperoxide 113 underwent a Baeyer-Villiger type 
rearrangement to form imino anhydride intermediate 114 which upon O-acyl to N-acyl migration 
led to triamide intermediate 115. The triamide 115 released N-benzoylbenzamide in a lactonization 
process to form 116 in 90% total yield.  Such rearrangements of imino anhydrides to triamides are 

























































































Themes on the synthesis of sterols via 1O2 chemistry have been reported.209 A 2011 report 
described the biomimetic synthesis of 5,6-dihydroglaucogenin C 124 (Scheme 25).210 One step 
involved the TPP-sensitized photooxidation of 118 yielding the hydroperoxide 119 in 99% yield. 
The resultant hydroperoxide 119 reacted by a ferrous ion-catalyzed homolysis of the O–OH bond, 
forming an alkoxy radical and subsequently a 3° carbon radical as transient intermediates. Addition 
of I2 led to an iodolactone, prior to a regioselective HI elimination affording 123 in 69% yield in 
2 steps. Evidence for the existence of a 3° carbon radical was due to trapping with TEMPO, when 










Scheme 25. Synthesis of 5,6-dihydro-glaucogenin C  
 
 
A 2013 report described the TPP-sensitized photooxidation of 126 in pyridine led to an 
ene reaction where treatment of the resulting hydroperoxide 127 with triphenylphosphine gave 
allylic alcohol 128 in 61% yield in 2 steps (Scheme 26).211 The synthesis of withanolide A 129 
required three additional steps. Additional fifteen unnatural anaolgs of 129 were prepared to probe 









Scheme 26. Synthesis of withanolide A 
 
 
A 1996 report featured the synthesis of bis(trifluoromethyl)imidazoline 134 from a MB-
sensitized photooxidation of pyrrole 130 (Scheme 27).212 A [2 + 2] cycloaddition on 130 with 1O2 
led to a dioxetane species in situ, which cleaved apart to the dicarbonyl compound, 131. To a lesser 
extent, the photooxidation of pyrrole 130 proceeded by a Diels-Alder reaction with formation of a 
methanol adduct 132 and water adduct 133 in 18% and 6% yields, respectively. Further steps led 
















Strategies have also been developed for accessing opioids via 1O2 chemistry, as the next 
two examples show. First, in 2000, a paper described the TPP-sensitized photooxidation of 
thebaine 135 which led to an opioid endoperoxide 136 in the expected [2 + 4] fashion, which on 
loss of an electron led to cyclohexene-1,4-dione 138 (Scheme 28).213 A second 1O2 molecule added 
by a [2 + 2] cycloaddition to form dioxetane 139 in situ. This di-singlet oxygenation process was 
followed by dioxetane ring-opening to formamide 140. Benzofuran 141 was a minor product and 









Scheme 28. Photooxidation of thebaine  
 
 
Second, in 2015, a report described the TPP-sensitized photooxidation of diene (R)-142, in 
which the R stereochemistry is at nitrogen (Scheme 29).214 Here, the singlet oxygenation of the 
diene quaternary salt led to the corresponding endoperoxide (R)-143 in 93% yield. The formation 
of (R)-methylnaltrexone 144 occurred after the hydrogenation of (R)-143.  










Scheme 29. Synthesis of (R)-methylnaltrexone  
 
 
6.3.9 Ring-Fused Examples 
Researchers have examined reactions of ring-fused compounds with 1O2, and four such 
examples are presented here. A 2011 report describes the TPP-sensitized photooxidation of 
cyclopentadienyl allo-cedrane 145 where the anti-endoperoxide 146 arose from attack of 1O2 on 
the less shielded bottom face of the diene (Scheme 30).215 This was followed addition of Zn and 
acetic acid to furnish cis-1,4-enediol 147 in 77% yield after 2 steps, which contained a paddlane 











Scheme 30. Synthesis of a tashironin-like compound  
  
Another intriguing example is from a 2009 report describing the synthesis of natural 
product (±)-phomactin A 152 (Scheme 31).216,217 One step in the synthesis involved a RB-
sensitized photooxidation of diene 149 that led to endoperoxide 150 in 65% yield.216 Singlet 
oxygen reacted from the more exposed site above the diene to reach endoperoxide 150, which 
reacted with KOAc and 18-crown-6 through a deprotonation reaction to give hydroxypyranone 
151 in 94% yield. Attempts to reduce the endoperoxide with as Lindlar’s catalyst, thiourea or 










Scheme 31. Synthesis of (±)-phomactin A 
 
 
A 2014 report describes the RB-sensitized photooxidation of 153 and 154 which gave 
4β,5β-epoxyxanthatin-1α,4α-endoperoxide 155 and 4α,5α-epoxyxanthatin-1β,4β-endoperoxide 
156 as a mixture in 70% yield (Scheme 32).219 Pure 155 and 156 were isolated by preparative 
HPLC. The formation of endoperoxide 155 was favored (ratio of 155:156 was 5:1) as the result of 









Scheme 32. Synthesis of epoxyxanthatin endoperoxides 
 
 
A 2009 report describes the MB-sensitized photooxidation of tridachiahydropyrone (157) 
which gave (±)-158 as colorless oil in 99% yield (Scheme 33).220 In this work, the structure of 157 
was revised, and (±)-158 was named as (±)-oxytridachiahydropyrone. HMBC, HMQC, and COSY 
data were collected, where 1O2 reacts selectively via attack on the bottom face of 157 for the 
exclusive formation of the endo product (±)-158. 
 












Strategies have been developed for accessing natural product phenols from 1O2 reactions, 
as we will see in this subsection. An approach reported in 2014 uses a the TPP-sensitized 
photooxidation of phenol 159 which led to its dearomatization (Scheme 34).221 Singlet oxygen 
added selectively to the opposite side of the shielding trimethylsilyl ether furnishing the 
hydroperoxy quinol 160. Quinol 161 was formed as a pink solid after the hydroperoxide group of 
160 was reduced with triphenylphosphine in 74% yield in 2 steps. X-ray crystal data were obtained 
for 161. Similar strategies on reduction of O–O bonds in peroxyquinols to form tertiary alcohols 
have been reported.222 Tertiary alcohol 161 was a substrate for further reactions leading to model 










Scheme 34. Synthesis of tigliane and daphnane-type compounds  
  
 
A 2015 report described the RB-sensitized photooxidation of (+)-methyllinderatin 164 
which led to dioxetane 165 by a 1O2 [2 + 2] cycloaddition (Scheme 35).223 An adjacent phenol 
oxygen attack of the nearby of the dioxetane 165 carbon accounts for the C–O ring opening to a 
diastereomeric mixture of hydroperoxides 166 and 167 in a 2:1 ratio with 76% yield. X-ray data 















A 2003 report described the synthesis of a bicyclo[4.3.0] compound (170) to reach a BCE 
ring system similar to the natural product ryanodine 171 (Scheme 36).224 Introduction of the 
endoperoxide group in 169 was accomplished regioselectively by the MB-sensitized 
photooxidation of 168. The hydrogenation of the endoperoxide O–O bond in 169 gave diol 170 in 










Scheme 36. Synthesis of the BCE Ring structure of ryanodine  
 
 
An approach reported in 2011 featured the MB-sensitized photooxidation of trans-
resveratrol (172) (Scheme 37).225 Notably, the main pathways are a [2 + 2] cycloaddition of 1O2 
that led to aldehydes 175 and 176, and a [2 + 4] cycloaddition of 1O2 that led initially to an 
endoperoxide, which upon heating rearranged to moracin M 177 and 2-hydroxacetaldehyde. This 
study is a rare example in natural products synthesis where the reaction rate constants were 
quantitated. The chemical quenching rate constant (kr) of 1O2 with trans-resveratrol 172 was found 










Scheme 37. Synthesis of moracin M 
 
 A 2008 report describes the MB-sensitized photooxidation of isoeugenol (178) (Scheme 
38).226 Here, a [2 + 2] cycloaddition of 1O2 led initially to a dioxetane species, which cleaved apart 
to vanillin 179 and acetaldehyde. The reaction is a mixed photooxidized system since 
dehydroisoeugenol 180 and other products arise by a type I photosensitized oxidation41 forming 
oxygen radical intermediates. Compound 181 may form by phenolic hydrogen abstraction in 179 
and radical addition to the aldehydic group of a second 179 molecule followed by hydrogen atom 
transfer. Mechanistically, condensation of 179 to furnish ester 181, likely involved a type I 
photosensitized oxidation to provide radicals for the ester coupling. Coniferyl alcohol also led to 
vanillin 179 (reaction not shown), although ferulic acid underwent a trans-cis C=C bond 
isomerization likely through zwitterionic peroxy intermediate analogous to (E,Z)-2,4-dimethyl-










Scheme 38. Synthesis of vanillin, dehydroisoeugenol and derivatives 
 
 
A 2014 report described the RB or Ru(bpy)32+—sensitized photooxidation of triacetate 182 
which was followed by reduction with triphenylphosphine, giving the tertiary alcohol 183 and 
secondary alcohol 184 in 62-71% yields (Scheme 39).230 The ratio of 183:184 was 2:1 for RB, but 
Ru(bpy)32+ produced an 8:1 ratio suggesting not only 1O2 but other oxygen species in the reaction. 
Three additional steps, including dehydration and a [2 + 4] cycloaddition led to kuwanon I (185) 
and kuwanon J (186). Related natural products, brosimone A and B, were also synthesized in a 










Scheme 39. Synthesis of kuwanons I and J  
 
 
A 2004 report used a the TPP-sensitized photooxidation of natural prenylated coumarins 
mammea A/AA (187), mammea A/BA, and mammea B/AA followed by reduction with 
triphenylphosphine led to disparinol A 189, isodisparinol A and disprorinol A in 60%, 63% and 
65% yields, respectively (Scheme 40).232 In addition to the prenylcoumarins, the importance of 
natural prenylxanthone photooxidations was also realized. For example, xanthone 190 led to 
hydroperoxides 191 and 192, and after reduction with triphenylphosphine, to allylic alcohol 193 
and a pyranoxanthone natural product 6-deoxyisojacareubine 194. A puzzling effect of 








of 188 was formed, but not isolated. The oxidations of prenylated natural products were of interest 
in terms of their bioactivity.233 
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(other regioisomer likely formed)
 
While the vast majority of 1O2 reactions use an external sensitizer as a strategy to synthesize 









6.3.11 Self-sensitized Examples 
There are self-sensitized examples to reach natural products, including a 1994 report 
described a self-sensitized photooxidation of anthracene 195 was used in the synthesis of (−)-
balanol 199 (Scheme 41).234 A 1O2 [2 + 4] cycloaddition with 195 led to endoperoxide 196. 
Protonation of the peroxide oxygen destabilizes the C–OO bond toward heterolysis, where 
hydration and then methoxide ion attack and ring-opening led to benzophenone derivatives 197 
and 198. Additional synthetic steps were carried out leading to (−)-balanol 199, which contains a 
benzophenone and a chiral hexahydroazepine. (−)-Balanol 199 is a potential inhibitor of protein 
kinase C.235  
 









A paper in 1991 has described a self-sensitized photooxidation of anthracene-1,5-diol 200 
(Scheme 42).236 Singlet oxygen was captured by 200 regioselectively at the 9,10-carbons leading 
to cycloadduct 201, which was reduced with NaBH4 and upon air oxidation led to anthraquinone 
202. Additional steps were required to reach vineomycinone B2 methyl ester 203.  
 
Scheme 42. Synthesis of vineomycinone B2 methyl ester  
 
  










Strategies have been developed that use indole photooxidation in the synthesis of natural 
products and analogs. We have located four studies, including a report in 2009 that TPP-sensitized 
photooxidation of indole 204 which led to hydroperoxide 205 (Scheme 43).237 Under acidic 
conditions, protonation of the hydroperoxide group in 205 causes water loss and carbonyl 
formation in oxindole 206 in 88% yield in 2 steps. Hydrogenation of 206 led to epimeric indoles 
207 and 208 in a 1:2 ratio in 97% yield. Indoles 207 and 208 contained the [2.2.1]
oxobicycloheptane core and thus are similar to the natural product welwistatin 209. Further 
synthesis on a range of alkylated and acylated indole derivatives of 207 and 208 was conducted 
where the alkylated derivatives were furnished in higher yields.  
 









A report in 2004 describes a secoporphyrazine-sensitized photooxidation of tryptophan 210 
(Scheme 44).238 Afterwards, deoxygenation of the hydroperoxide by dimethylsulfide formed 
hydroxypyrroloindole diastereoisomers 212 and 213 in 1:1 ratio in 58% combined yield. The 
anthelmintic natural compound (-)-CJ-12662 214 was prepared in 4 further steps. 
Secoporphyrazine is less commonly used in synthesis, but is a good sensitizer239 which gave a high 
yield of a triplet state that is capable of efficient energy transfer to oxygen to form 1O2.240,241 The 
hydroxypyrroloindoles 212 and 213 originated from a 1O2 [2 + 2] cycloaddition and deoxygenation 
of dioxetane by dimethylsulfide followed by nucleophilic attack at C2 by the amide nitrogen, and 










Scheme 44. Synthesis of the natural product (-)-CJ-12662  
  
 
A report from 2001 describes the synthesis of okaramine N 218 (Scheme 45).246 Because 
the azocane-fused indole reacts readily with 1O2, it was protected with the enophile N-
methyltriazolinedione (MTAD). The N–H allylic bond in diketopiperazine 215 reacted with 
MTAD by an ene reaction to reach urazole 216, which enabled a regioselective photooxidation of 
the tethered indole in intermediate 216. The RB-sensitized photooxidation of 216 was followed by 








the thermal release of MTAD in a retro-ene reaction led to okaramine N 218 in 70% yield in 4 
steps. This reaction is unique because it protected the fused indole site and more substituted C2–
C3 indole bond,247 which capitalized on ene reactions with MTAD that have been characterized 
previously.248-257 
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An approach reported in 2012 described the synthesis of (-)-melohenine B (223) in 99% 








Notably, the ratio of epimers 219 and 220 was unimportant because the path sequence (dioxetane 
cleavage then hydroxypiperidine ring-opening or visa versa) ended with a stereospecific ring 
reclosure to reach (-)-223.259,260 Molecule curvature was of importance where singlet oxygen added 
regioselectively via the convex side of 219 and 220. The dioxetane intermediates (221 and 222) 
were formed, where C14 equilibration through an aldehyde intermediate 226, which also 
equilibrated with dioxetane 221. The position of the hydroxyl group at C14 was assessed from X-
ray data of (-)-223.  
 











6.3.13 Lactams and Related Examples 
This subsection provides eight examples where singlet oxygen was used in the synthesis 
of natural product lactams. The first is a historical example with the synthesis of intermediate 229 
reported in 1984 by an enamine—singlet oxygen reaction (Scheme 47).261 A 
bisacenapthalenethiophene (BANT)-sensitized photooxidation of 227 led to tricarbonyl 228 in 
42% yield. The enamine site in 227 was cleaved by 1O2 to form the vicinal tricarbonyl system in 
228. The facile cleavage of enamines by singlet oxygen to form carbonyl derivatives has utility 
not only in the synthesis of β-lactams, but also ketones, lactones and esters.262-264 Upon desilylation 
and intramolecular cyclization by attack of the lactam nitrogen on the center carbonyl group of 
228 followed by reaction with TMSI led to 229. Compound 229 has served as a precursor in the 
synthesis of antibiotic (±)-PS-5 230.265 
 












A 2015 report266 describes the MB-sensitized photooxidation of difuran 231 where MB 
played a dual role, one as a sensitizer and the other as a redox catalyst (Scheme 48). After the 
photoreaction, dimethylsulfide was added and subsequently ammonia, which led to the formation 
of 1,5-dihydro-pyrrol-2-one 232. After concentrating the mixture, it was dissolved in chloroform 
containing molecular sieves (4 Å) and TFA to give pandamarine 233 in 30% overall yield. This 
MB sensitizer and redox catalyst approach266,267 has enabled the access to other units 
(diazaspiro[4,5] and 5-ylidenepyrrol-2(5H)-one) common in natural products and drugs.268-272 
 
Scheme 48. Synthesis of pandamarine  
 
A 2014 report describes the RB-sensitized photooxidation of difuran 234 which led to a 
tandem addition of 1O2 (Scheme 49).273 After solvent removal, the residue was placed in pyridine 
with acetic anhydride, followed by the addition of TMSBr leading to methoxybutenolide 235 as a 
single diastereomer in 75% yield. Addition of H2SO4 to a solution of butenolide 235 led to 








the latter in a 7:3 ratio. While not lactam forming, we thought it is logical to be included in this 
subsection since a unique spiro-N,O-acetalization and elimination took place to form a spiro-
lactone-piperidine structure in 236 and its rearranged lactone-pyrrolidine structure in 237. Another 
example of the furan topic is a 1995 report on the RB-sensitized photooxidation of 
trimethylsilylfuran 238 in the presence of DIPEA which led to 239 in 99% yield (Scheme 50).274 
The presence of the trimethylsilyl group improved the yield of butenolide formation.201,275 
Butenolide 239 underwent further reactions to reach (-)-PI-091 240, a platelet aggregation 
inhibitor.274 
 
Scheme 49. Synthesis of pandamarilactone-1  
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An approach reported in 2013 featured the RB-sensitized photooxidation of furan 241 
followed by the addition of dimethylsulfide and then of 3,4-dimethoxyphenethylamine led to 
lactam 243 in 54% yield (Scheme 51).276 The cyclization process is rationalized by intermediate 
242, where an additional step led to 1,5-dihydro-pyrrol-2-one 244. Compound 244 contains the 










Scheme 51. Synthesis of a tetracyclic compound similar to the natural product erysotramidine  
 
 
A 1993 report described the reaction of bipyrrole 246 with 1O2 by a [2 + 4] cycloaddition 
reaction (Scheme 52).277 This reaction led to the D,L and meso forms of isochrysohermidin (248 
and 249) in 42% combined yield in a 1:1 ratio. The photooxidation of pyrroles have been shown 
to have utility in the synthesis of 1,5-dihydro-pyrrol-2-ones.278 An example is shown below. The 
singlet oxygenation of pyrrole 250, in which RB was the photosensitizer gave 1,5-dihydro-pyrrol-
2-one 252 in 92% yield (Scheme 53).279 The reaction produced the endoperoxide 251 before the 
decarboxylation and formation of 252. Pyrroles and related indolizines also tend to undergo type 









Scheme 52. Synthesis DL and meso isochrysohermidin  
 
 
Scheme 53. Synthesis of a 1,5-dihydro-pyrrol-2-one  
 
 In conclusion, Section 4 described batch reactions which have been established using 1O2 
in the synthesis of natural products and analogs. There is continuity between batch 










6.4 Singlet Oxygen in Flow Synthesis  
6.4.1 Background 
We now turn to 1O2 flow photoreactors and discuss their success in synthesis to date. 
Schemes 54-66 show the extent of compounds synthesized thus far, including juglone, butenolides, 
rose oxide and artemisinin. Flow experiments to synthesize compounds of high complexity as seen 
in Section 4 have not yet emerged. Also, reports of tandem addition of singlet oxygen molecules 
in flow reactions are absent from the literature. 
In what follows, 1O2 microflow and macroflow photosystems are described, where Figures 
1 and 2 provide illustrations, respectively. There are 20 studies that have used micro- or macroflow 
1O2 photoreactors in synthesis. Photoreactors have also been used to produce airborne 1O2, but will 
not be described.285-289 For example, a Pyrex-tube flowing 1O2 was developed,285 where reaction 
rate data for 1O2 with alkenes was reported in the gas phase (Figure 3), but this device is not 
compatible with organic synthesis because of a very rapid oxygen sparge rate, which would cause 
solvent evaporation. 
We provide accounts of four 1O2 photoreactor geometries (i) microflow reactor, (ii) 
macroflow reactor, (iii) supercritical carbon dioxide reactor, and (iv) bubbling reactor in 
subsections numbering from 6.4.1-6.4.5 below. We start our discussion by presenting examples of 










Scheme 54. Flow reactor photooxidation of α-terpinene  
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 Scheme 55. Flow reactor photooxidation of α-pinene 
 
 



















































































Scheme 64. Flow reactor photooxidation of dihydroartemisinic acid  
 
 

























Figure 1. A microflow system capable of generating 1O2 in micrometer sized channels. LED or other light sources are often positioned above the plate. 
 
 
Figure 2. A macroflow system capable of generating 1O2 a in millimeter sized channel. Optical energy is delivered from a light source with transparent tubing coiled around it. Reagents are 




















6.4.2 Singlet Oxygen Microphotoreactors  
We have located 11 studies that use microflow photoreactors with solution-phase and 
immobilized sensitizers (Sections 6.4.2.1 and 6.4.2.2).  
 
6.4.2.1 Microphotoreactors with Solution-Phase Sensitizer 
In 2013, a paper reported that ascaridole 254 and byproduct p-cymene 255 were formed in 
90% total yield from a RB-sensitized microflow photooxidation of α-terpinene 253 (Scheme 
54).290 Byproduct p-cymene 255 arises from a type I photosensitized oxidation process. The device 
consisted of a microcapillary film (MCF) with 10 parallel channels. Oxygen mass-transport was 
enhanced by using degassed solvent, where O2 was transported through a fluorinated ethylene 
propylene (FEP) microcapillary film. Here, space-time yields were found to be 20 times greater 
compared to a batch reaction. A similar reaction was studied in 2002,291 where ascaridole 254 
(85% yield) was also formed from RB-sensitized flow photooxidation of α-terpinene 253 using a 
glass microchip device with etched channels.292,293 
A 2014 report described pinocarvone 257 was synthesized from a TPP-sensitized 
microflow photooxidation of α-pinene 256 (Scheme 55).294 The system was a microreactor-LED 
where the reaction led to pinocarvone 257 in pyridine with DMAP and acetic anhydride, as was 
previously established.295 Space-time yields for the microreactor were found to be 3-7 times higher 
than other reactors, including an immersed-well and an annular flow system. 
A report in 2007 focused on a Ru(bpy)32+—sensitized microflow photooxidation of (S)-(-)-
β-citronellol 259 (Scheme 56).296,297 The device consisted of a blue LED light source and 








irradiated for 60-70 h. The yield for 260 was 60%, and for 261 was 40% by HPLC. The 
corresponding alcohols were formed after reduction with Na2SO3. Yields were found to be only 
slightly higher for the microflow reactor compared to the batch reactor, which used a Xe-lamp.  
A falling-film microreactor was reported in 2005 to synthesize 2-cyclopenten-1,4-diol 267 
in 20% yield from RB-sensitized microflow photooxidation of cyclopentadiene 265 (Scheme 
57).298,299 The reactor consisted of a plate with 32 parallel microchannels along with a Xe lamp. 
The film flowed downward simply as a consequence of gravity. After exiting the reactor, the 
endoperoxide 266 is reduced to cis-cyclopent-4-ene-1,3-diol 267 with thiourea. There was no 
optimization of this flow reaction.  
In 2011, a paper described a dual microreactor to synthesize allylic alcohol 262 and 263 in 
95% yield (262:263 = ratio 1.0:1.5) from a MB-sensitized microflow photooxidation of citronellol 
259 (Schemes 56 and 58A).300 The products were analyzed after treatment of hydroperoxides 260 
and 261 with NaBH4 in methanol. The device used a white LED light source, but was unique. It 
contained a polyvinylsilazane (PVSZ)-line dual-channel where liquid flow and oxygen flow 
channels were separated by a PDMS layer. The PDMS is gas permeable and permitted rapid 
saturation of the solution with oxygen. Reaction times ranged from 2-3 min. Other substrates were 
photooxidized, including α-terpinene 253 that gave ascaridole 254 (91% yield), and allylic 
alcohols 268 (R = H or Me) to give hydroperoxides 269 (R = H or Me) in 99% yield. The relative 
efficiency of the dual channel system was found greater than a mono-channel system due to a more 
efficient oxygen mass transfer process. Furthermore, the efficiency of the dual-channel system was 
2.6-fold higher compared to a batch reaction. 
A 2014 report describes a microreactor that was fabricated to synthesize ascaridole 254 in 








are also data for the 1O2 microreaction with naphthalene-1,5-diol 272 to give juglone 273 in 92% 
yield (Scheme 59A) and also the 1O2 microreaction with citronellol 259 to give allylic 
hydroperoxides 260 and 261 in 92% yield. Ring opening of an initially formed dioxetane can take 
place (Scheme 60). For example, the reaction of 2-(3-methoxyphenyl)-3-methyl-1-benzofuran 278 
with 1O2 formed 2-acetylphenyl-3-methoxybenzoate 280 in 97% yield. The device consisted of 
borosilicate glass with channels and a serpentine section, and used an OLED light source. This 
particular microphotoreactor did not outperforming a batch reaction. However, the thinking was 
to wrap the flexible OLED white light source around the reactor, which seemed very reasonable.  
Lastly, in 2012, a report described the sulfamidic Zn phthalocyanine-sensitized microflow 
photooxidation with 9,10-dimethylanthracene 281 in DMF (Scheme 61A).302 In this case, a high-
pressure mercury lamp was the light source, and samples were followed by HPLC. The data 
showed that the microreactor could photooxidize the anthracene 281 more rapidly than in a batch 
reactor. 
 
6.4.2.2 Microphotoreactors with Immobilized Sensitizers  
Heterogeneous 1O2 sensitizers have been used in flow, although they are few in number. 
We have located 3 studies that use microflow photoreactors with immobilized sensitizers, i.e. the 
solution is devoid of any sensitizer. It is expected that sensitizers such as porphyrins and fullerenes 
would remain powerful sensitizers for the production of 1O2 when immobilized in the photoreactor. 
However, restoring of photobleached sensitizer sites has not yet been accomplished. 
A 2012 paper reported on immobilized tri(N-methyl-4-pyridyl)porphyrin sensitized 
microflow photooxidations of α-terpinene 253, citronellol 259, and cholesterol 285 and other 








consisted of a glass microfluidic system with 16 parallel channels that had tetraaryl porphyrin 
covalently attached through a thiourea bridge to photogenerate 1O2. Samples collected from the α-
terpinene 253 and citronellol 259 experiments were monitored by HPLC and LCMS. The singlet 
oxygenation of cholesterol 285 led to 5R-hydroperoxycholesterol 286, where the reaction also 
provides a route to 7R/7β-hydroperoxy and 6R/6β-hydroperoxy cholesterol byproducts by oxygen 
radicals and not a 1O2 reaction. The product forming efficiency of the microfluidic system was 
higher than in a batch reaction. Other reports also describe cholesterol hydroperoxides and 
epoxides that are carcinogenic or mutagenic,304 and their formation by photosensitized production 
of singlet oxygen (type II) and oxygen radicals (type I).  
 
Scheme 67. Structure of the glass-attached porphyrin 
  
 
A 2006 paper describes the generation of p-benzoquinone 276 from a silica bead-supported 
tetraaryl porphyrin-sensitized microflow photooxidation of phenol 274 after 42 s in buffer solution 








intermediate, but the p-benzoquinone oxidatively processed to CO2 and maleic or fumaric acid. p-
Catechol is also a known product of phenol photooxidation.306 The device consisted of PTFE 
microchannels with silica beads bearing a covalently bound porphyrin through a pyridinium ion 
bridge to photochemically generate 1O2. The silica beads were stationary and resided at the bottom 
of the microchannels. The activity of this microflow system was higher than the silica beads in 
suspension based on the photooxidative decomposition of phenol.  
 






In 2008, a report appeared on a microreactor to synthesize ascaridole 254 in 94-97% yields 
in 40-50 s from [60]fullerene-sensitized microflow photooxidation of α-terpinene 253 in toluene 








gave the corresponding sulfoxide nearly quantitatively (Scheme 63). The device consisted of 
thiolene microfluidic channels and a white LED light source. Tentagel-supported or silica gel-
supported [60]fullerene beads were packed into the microchannels and held in by a filter. The 
microreactor led to higher product yields compared to a batch reactor that used a tungsten halogen 
lamp. In the past, fullerene-containing polymers in 1O2 jet-type generators pumped by LEDs have 
also been used.308 
 
Scheme 69. Structures of the tentagel-supported (A) and silica gel-supported (B) [60]Fullerene  
 
 
In conclusion, some eleven 1O2 microflow reactions have been reported in the literature.290-
303,305,307 As we will see below, relative to microflow about half of this number has been reported 
for 1O2 macroflow reactions.  
 
6.4.3 Singlet Oxygen Macrophotoreactors 
There have been five reports of 1O2 macroflow reactors that feature dissolved sensitizers 









6.3.4.1 Macrophotoreactors with Solution-Phase Sensitizer  
A 2012 report described the synthesis of artemisinin 301 in a 1.36 g quantity (39% yield) 
from a TPP-sensitized macroflow photooxidation of dihydroartemisinic acid 297 (Scheme 64).309 
The device was a macro fluorinated ethylene polymer (FEP) tubing system coiled around an Hg 
lamp. A flowing dihydroartemisinic acid 297 in an acidic solution of CH2Cl2 led to formation of 
hydroperoxide 298 in 91% conversion and 75% yield. Through a protonated hydroperoxide, Hock 
cleavage of 298 led to 299, which added 3O2 and followed by condensation steps, reaches 
artemisinin 301.310 Only minor quantities of other hydroperoxides were formed, where byproducts 
included a 5-membered and 6-membered lactone. Due to therapeutic interest, there are additional 
reports on synthetic artemisinins as powerful antimalarial APIs.311 Also, it may be noted 2015 
Nobel Prize in Physiology or Medicine was for the antimalarial drug artemisinin where 1O2 was 
used in its total synthesis.312-314 
In 2014, a paper appeared where α-aminonitriles were synthesized in 71-99% yields from 
TPP-sensitized macroflow photooxidation of primary and secondary amines followed by the 
addition of TMSCN in CH2Cl2 (Scheme 65).315 Oxidative cyanation could be accomplished over 
oxidative coupling. For example, 302 was converted to its corresponding nitrile 304. The device 
consisted of macro FEP tubing and a 420-nm LED light source, and had variable-temperature 
control. The oxidative cyanation was favored at -50 °C, whereas at higher temperature (25 °C), the 
dimer formed from oxidative coupling and cyanide addition. The product percent yield was high 
and only depended slightly on the amine structure as was studied in detail. This macroflow method 
may be useful for 1O2-based syntheses of unprotected amino acids on an industrial scale, which 
could in turn serve as templates for peptide synthesis.316 Previous synthetic batch reactions have 








We have only located one study that provided a macroflow reaction of 1O2 with sulfides. 
In 2011, a paper described the formation of sulfoxide 295 and sulfone 296 (95% yield, 295:296 
ratio 3:1) in a TPP-sensitized macroflow photooxidation of 2-(ethylmercapto)-ethanol 294 in a 
biphasic mixture (Scheme 63).319 The device consisted of a macro FEP tubing was coiled around 
an Hg lamp. Further evidence for the utility of the flow system was the photooxidation of other 
substrates, α-pinene 256 (alcohol product 258, 63% yield), α-terpinene 253 (ascaridole 254, 85% 
yield), 2-methylfuran 306 (to reach ketoacid 309, 68% yield) and citronellol 259 (after reduction 
with sodium sulfite to reach diols 262 and 263, in a ratio of 1.1:1.0, 22.8 g, 88% yield) (Schemes 
55 and 66). In the case of 2-methylfuran 306,319 the approach features the presence of 1.25 eq 
DIPEA followed by addition of pyridine in THF and acetone to reach ketoacid 309, 68% yield. As 
noted in Sections 4.1 and 4.13, 1O2 reaction efficiencies can be reduced in the presence of amines 
such as DIPEA. The flow photooxidation of methionine was less productive (4.5 mg/h) compared 
to the photooxidation of α-terpinene (10 mg/h),307 which may not be unexpected. For some 
sulfide—singlet oxygen reactions, cleavage occurs through a hydroperoxysulfonium ylide that 
affords aldehydes or disulfides.320-322  
A 2008 report found that 1,3-diphenylisobenzofuran 320 reacted with 1O2 and formed 322 
in 34% yield from a porous silicon nanocrystal-sensitized macroflow photooxidation in CH2Cl2 
(Scheme 66).323 The device consisted of an annular flow reactor with either an Ar+ laser (488 nm) 
or a green LED (524 nm) light source, although evidence was not provided on whether the silicon 
nanocrystal was functioning as a sensitizer.  
A 2015 report described a RB-sensitized macroflow photooxidation of 5-
hydroxymethylfurfural 310 in aqueous alcohol mixtures formed intermediate 311 which led to 








was coiled around a fluorescent lamp. One optimized condition used a solution of 5-
(hydroxymethyl)furan-2-carbaldehyde 310 in i-PrOH/H2O (1:1), which first led to the 
corresponding endoperoxide 311, and then to butenolide 312 (93% yield). As desired, trace 
amounts of 313 and 314 were formed with i-PrOH/H2O, whereas greater amounts were formed 
with methanol or ethanol. A thermal isomerization of butenolide 312 led to oligomers of 315. 
Previously, the syntheses of butenolide 312 from endoperoxide 311 has been reported.325-327 
Butenolides have been extensively studied in batch reactions of 1O2. For example, 
observations that singlet oxygen react with furans to produce butenolides and spiroketal natural 
products was an important discovery.328-342 Much synthetic utility has been found, one example of 
a batch reaction is shown in Scheme 70.328 Here, the synthesis of a tetraquinane oxa-cage 
bislactone structure in parasecolide 325 occurred from the MB-sensitized photooxidation of furan 
323 at 0 °C.328 Afterwards, 5-hydroxybutenolide 324 was heated to 110 °C for a [2 + 4] 











Scheme 70. Synthesis of (±)-paracaseolide A  
 
 
In conclusion, Section 6.4.3 describes macrophotoreactors that have been established for 
using 1O2 in synthesis. Singlet oxygen macrophotoreactors with immobilized sensitizers with 
conventional solvents have so far not been reported. 
 
6.4.4 Supercritical Carbon Dioxide 1O2 Photoreactor 
Next, we describe examples of 1O2 flow reactors that used supercritical CO2 with sensitizer 
in the liquid phase (Section 6.4.4.1) and immobilized (Section 6.4.4.2). There are advantages in 
using supercritical CO2 such as safety (it is non-flammable), and enhanced O2 solubility and the 
reactions give higher product yields, due to longer 1O2 lifetimes (5.1 ms under the conditions) to 
overcome mass-transfer limitations of conventional solvents. O2 solubility in CO2 is higher than 









6.4.4.1 Supercritical Carbon Dioxide Photoreactors Using Dissolved Sensitizer 
A 5,10,15,20-tetrakis(pentafluorophenyl)porphyrin (TPFPP)-sensitized macroflow 
photooxidation in supercritical CO2 was reported in 2009 to generate hydroperoxides 260 and 261 
in 52% and 48% yields, respectively, from citronellol 259 after 4 h (Scheme 56).343 The TPFPP 
sensitizer was dissolved in the liquid. The device was tubular in shape with a sapphire cell mounted 
in a flow system where the light source was a white LED. The product hydroperoxides 260 and 
261 were reduced after exiting the apparatus in an aqueous solution of Na2SO3. Space-time yields 
were ~9 times higher in this macroreactor compared to a batch reaction. 
 
6.4.4.2 Supercritical Carbon Dioxide Photoreactor Using an Immobilized Sensitizer  
A macroflow photooxidation in supercritical CO2 was reported in 2011 to convert 
citronellol 259 to hydroperoxides 260 and 261 in 88% yield, and α-terpinene 253 to ascaridole 254 
in 85% yield (Schemes 56 and 71).344 The device was a packed sapphire flow system, in which 4 
immobilized sensitizers were examined (Scheme 71A-D). For example, 5,10,15,20-tetrakis(2,6-
dichlorophenyl)porphyrin (TDCPP) was tethered through an amide bridge to polyvinyl chloride 
(PVC) and loaded in the device with glass wool. Under the conditions, the 1O2 lifetime was found 
to be 5.1 ms, which far surpasses typical tens of microsecond lifetimes in organic solvents. 
Previously, supercritical CO2 reactions have been used with 1O2.345-348 Other photochemical 
reactors have been reported for the synthesis of organometallic compounds in supercritical CO2 or 










Scheme 71. Structures of the immobilized sensitizers in flow devices: (A) rose bengal covalently 
bound to polystyrene, (B) TDCPP derivative covalently bound to PVC, (C) TDCPP adhered to 






6.4.5 Bubbling Photoreactors 
Singlet oxygen bubbling reactors have been scarcely studied. In this section we describe 
examples of two 1O2 bubbling reactors. One used a dissolved sensitizer in solution (Section 
6.4.5.1), and the other used a heterogeneous sensitizer shielded from solution behind a membrane 









6.4.5.1 Bubbling Photoreactor Using a Dissolved Sensitizer  
A 2012 report describes juglone 273 synthesized in 70% yield in a RB-sensitized bubbling 
photooxidation of 1,5-dihydroxynaphthalene 272 in t-AmOH/H2O (9:1) (Scheme 59A).352 The 
apparatus consisted of a Pyrex glass tube which was situated in between two fluorescent lamps. 
This bubbling reactor is unique and is somewhat similar to a batch system, but with a rising airflow. 
Bubble diameters were ~50-100 µm, where water-poor media flowed gas via bullet-shaped 
bubbles. Various solvents were used, such as i-PrOH, i-PrOH/H2O (9:1), t-AmOH/H2O (9:1), 
EtOH/H2O (9:1), MeOH/H2O (9:1). High product yields were observed for the conversion of α-
terpinene 253 to ascaridole 254 (71% yield), citronellol 259 to hydroperoxides 261 and 262 (88% 
yield, ratio 1.1:1.0), and furfural 317 to 5-hydroxyfuran-2(5H)-one (γ-hydroxybutenolide) 318 
(>95% yield). 
 
6.4.5.2 Bubbling Photoreactor Using a “Shielded” Heterogeneous Sensitizer  
An SMA modified device with dry Si-phthalocyanine particles was reported in 2012 in a 
bubbling photooxidation of trans-2-methyl-2-pentenoic acid 270, 9,10-anthracene dipropionate 
dianion 283, N-benzoyl-D,L-methionine 290 and N-acetyl-D,L-methionine 292 in D2O and H2O 
(26-46% yields) (Schemes 51 and 63).353,354 The device chamber was loaded with Si-
phthalocyanine glass sensitizer particles, which resided behind a microporous membrane with 
pores that excluded water. An O2 gas feed tube and a red diode laser via a fiber optic were coupled 
to the SMA device. Bubbles were generated enriched with 1O2, which left behind no waste or by-
products other than 3O2. The photooxidation reaction rate was shown to increase in O2-poor than 








In conclusion, there are several 1O2 photoreactor types that have been developed. These 
include micro and macroreactors. We have seen that (i) high product yields were achieved for flow 
systems in short periods of time, (ii) sensitizers immobilized in the reactor itself were 2-times less 
studied than homogeneous sensitizers, and (iii) about half of the studies reported 1O2 flow relative 
to batch conditions with an improved efficiency for flow.  
 
6.5 PROSPECTIVES  
6.5.1 State of 1O2 Synthetic Science 
Sections 6.3 and 6.5 present the interplay of basic and applied reactions of 1O2 in synthesis, 
respectively. Batch photooxidations in Section 4 have been used with success for decades, but are 
subject to fundamental limitations. Problems emerge when batch reactions are scaled up, including 
(i) long reaction times, (ii) sensitizer photobleaching, (iii) mass-transfer limitations between 
oxygen and the substrate, and (iv) inner filter effects (large volumes increase the optical pathlength 
where light can be blocked from reaching the sensitizer). 
Even though fewer publications exist for 1O2 flow reactions compared to batch reactions, 
the former has advantages, including (i) short reaction times when scaling up, (ii) reduced 
sensitizer photobleaching, (iii) high surface-to-volume ratios for high 1O2—substrate mixing, (iv) 
lack of inner filter effect problems, (v) high sensitizer concentrations can be used concurrent with 
high transmittance and photon flux, (vi) O2-deprived solutions enhance 1O2 delivery by mass 
transfer assistance (while paradoxical, less oxygen in solution leads to greater oxygenation). 
The utility of singlet oxygen photoreactors in synthetic organic chemistry has emerged. 
Disappointingly, 1O2 flow reactions are not as popular as batch reactions, leading us to ask: Why 








assembly of the photoreactor is required, (ii) there are questions about interchangeability of parts 
and system configurations, and (iii) flow reactors cannot commonly be purchased “off the shelf”.  
 
6.6 Summary and Outlook  
Progress has been made regarding 1O2 in the organic synthesis of complex targets. 
Synthesis of natural products is often modeled on possible 1O2 biosynthetic routes. Thus, 
biomimetic 1O2 reactions that use alkene and diene precursors are common; however, fewer 
examples are known with polyenes, di- and polysulfides, and amines due to their facile physical 
quenching of singlet oxygen (1O2  3O2).356-361 Singlet oxygen can be used widely, but except for 
artemisinin362-365 and rose oxide,366 no 1O2 reactions have yet been used in the pharmaceutical 
industry. Consequently, one may look forward to estimate what is likely to happen in the field. 
What are the future prospects of 1O2 in synthetic chemistry? It seems the combination of 
fundamental and applied research is beneficial in a reciprocal manner (compare Sections 6.3 and 
6.4). The connection between flow technology and synthesis of simple natural products was 
noticed. It was recognized that the ongoing use of batch reactions for large quantities has 
drawbacks, therefore new flow options can provide answers.  
In closing, we look back to pioneers of 1O2 in synthetic and natural products chemistry.3 
This brings organic chemistry to the front, in reminding us of the first efforts of Foote and Wexler 
some 50 years ago.1,2 Here, the success of research was not only assured, but also reaffirmed by 
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